text:
 Tärkeä oikeudellinen huomautus
 |
 52006PC0510
 Ehdotus neuvoston päätös bmuuntogeenisen maissin (Zea mays L. linja T25) käytön ja myynnin väliaikaisesta kieltämisestä Itävallassa Euroopan parlamentin ja neuvoston direktiivin 2001/18/EY mukaisesti (Ainoastaan saksankielinen versio on todistusvoimainen) /* KOM/2006/0510 lopull. */
 [pic] | EUROOPAN YHTEISÖJEN KOMISSIO |Bryssel 9.10.2006KOM(2006) 510 lopullinenEhdotusNEUVOSTON PÄÄTÖSbmuuntogeenisen maissin (Zea mays L. linja T25) käytön ja myynnin väliaikaisesta kieltämisestä Itävallassa Euroopan parlamentin ja neuvoston direktiivin 2001/18/EY mukaisesti(Ainoastaan saksankielinen versio on todistusvoimainen)(komission esittämä)PERUSTELUT1. Muuntogeenisen maissin ( Zea mays L. linja T25) markkinoille saattamiseen on annettu lupa direktiivin 90/220/ETY C osan mukaisesti tehdyillä komission päätöksillä ja Ranskan viranomaiset ovat antaneet luvan tämän muuntogeenisen organismin markkinoille saattamiseen.2. Direktiivin 90/220/ETY 16 artiklan (suojalauseke) mukaisesti Itävalta ilmoitti tämän jälkeen komissiolle päätöksestään kieltää väliaikaisesti kyseessä olevan muuntogeenisen maissin ( Zea mays L. linja T25) käyttö ja myynti tai rajoittaa niitä sekä syyt tähän.3. Asiasta kuultiin kasveja käsittelevää tiedekomiteaa, joka katsoi, että Itävallan esittämät tiedot eivät sisällä sellaista uutta ja olennaista tieteellistä todistusaineistoa, jota ei olisi otettu huomioon, kun kyseisten muuntogeenisten organismien riskejä alun perin arvioitiin, ja joka edellyttäisi komitean Zea mays L. linja T25 -tuotteen turvallisuudesta antaman alkuperäisen tieteellisen lausunnon tarkistamista.4. Direktiivi 90/220/ETY on kumottu geneettisesti muunnettujen organismien tarkoituksellisesta levittämisestä ympäristöön annetulla Euroopan parlamentin ja neuvoston direktiivillä 2001/18/EY[1].5. Tammikuussa 2004 komissio pyysi Itävaltaa harkitsemaan uudelleen suojalausekettaan uusien sääntelypuitteiden perusteella ja ilmoittamaan siitä tarvittaessa uudelleen direktiivin 2001/18/EY mukaisesti.6. Itävalta toimitti direktiivin 2001/18/EY 23 artiklan mukaisesti komissiolle lisätietoja olemassa olevan suojalauseketoimenpiteensä tueksi.7. Direktiivin 2001/18/EY 23 artiklassa edellytetään, että komissio tekee päätökset direktiivin 30 artiklan 2 kohdassa säädettyä menettelyä noudattaen, ja kyseisessä kohdassa viitataan päätökseen 1999/468/EY.8. Komissio pyysi direktiivin 2001/18/EY 28 artiklan 1 kohdan mukaisesti lausuntoa Euroopan elintarviketurvallisuusviranomaiselta (EFSA), joka on perustettu Euroopan parlamentin ja neuvoston asetuksella (EY) N:o 178/2002[2] ja joka kyseisen asetuksen nojalla on korvannut asiaa käsittelevät tiedekomiteat. Euroopan elintarviketurvallisuusviranomainen katsoi 8 päivänä heinäkuuta 2004 antamassaan lausunnossa[3], että Itävallan esittämät tiedot eivät sisällä uutta tieteellistä todistusaineistoa, joka mitätöisi Zea mays L. line T25 -tuotteen ympäristöriskien arvioinnin ja antaisi tästä syystä oikeutuksen kyseisen muuntogeenisen organismin kieltämiseen Itävallassa.9. Luonnos komission päätökseksi, jossa Itävaltaa vaadittiin kumoamaan kansallinen suojalausekkeensa, toimitettiin neuvoston päätöksen 1999/468/EY 5 artiklan 2 kohdan mukaisesti lausuntoa varten direktiivin 2001/18/EY 30 artiklan mukaisesti perustetulle komitealle.10. Komiteaa kuultiin 29 päivänä marraskuuta 2004 mutta se ei antanut lausuntoa suojalauseketoimenpiteestä, jolloin komission on neuvoston päätöksen 1999/468/EY 5 artiklan 4 kohdan mukaisesti tehtävä viipymättä neuvostolle ehdotukset tarvittavista toimenpiteistä ja annettava tästä tieto Euroopan parlamentille.11. Ympäristöneuvosto ilmoitti kuitenkin neuvoston päätöksen 1999/468/EY 5 artiklan 6 kohdan mukaisesti 24 päivänä kesäkuuta 2005 määräenemmistöllä vastustavansa ehdotusta, jonka mukaan Itävallan olisi kumottava suojalauseketoimenpiteensä, ja näin ollen komission on tarkasteltava ehdotustaan uudelleen.12. Neuvosto totesi lausumassaan, että kyseisen muuntogeenisen maissilajikkeen T25 markkinoille saattamiseen liittyvästä kansallisesta suojatoimenpiteestä vallitsee edelleen tietynasteinen epävarmuus, ja kehotti komissiota hankkimaan lisää näyttöä kyseisestä muuntogeenisestä organismista sekä arvioimaan, onko kyseisen organismin markkinoille saattamisen väliaikainen lykkääminen oikeutettu varotoimenpide Itävallassa ja onko sen markkinoille saattamisen salliminen edelleen direktiivissä 2001/18/EY säädettyjen turvallisuusvaatimusten mukaista.13. Marraskuussa 2005 Euroopan elintarviketurvallisuusviranomaista kuultiin siitä, voidaanko tieteellisin perustein katsoa, että Zea mays L. linja T25 -tuotteen markkinoille saattamisen jatkamisella on lupaehtoja noudatettaessa todennäköisesti haitallisia vaikutuksia ihmisten terveyteen tai ympäristöön, ja sitä pyydettiin erityisesti ottamaan huomioon tieteelliset tiedot, joita oli mahdollisesti ilmaantunut sen aiemman tieteellisen lausunnon jälkeen, jossa oli arvioitu näiden muuntogeenisten organismien turvallisuutta.14. Euroopan elintarviketurvallisuusviranomainen totesi 29 päivänä maaliskuuta 2006 antamassaan lausunnossa[4] (julkaistu 11 päivänä huhtikuuta 2006) tutkittuaan Itävallan hakemuksessa esitetyt todisteet, että nykyään saatavilla oleva tieteellinen näyttö ei tue Itävallan esittämiä väitteitä ja ettei ollut syytä uskoa Zea mays L., linja T25 -tuotteen markkinoille saattamisen jatkamisella lupaehtoja noudatettaessa olevan haittavaikutuksia ihmisten tai eläinten terveyteen taikka ympäristöön.15. Neuvoston päätöksen 1999/468/EY 5 artiklan 6 kohdan mukaisesti komissio voi sen vuoksi tehdä neuvostolle muutetun ehdotuksen, tehdä ehdotuksensa uudelleen tai antaa perustamissopimukseen perustuvan säädösehdotuksen.16. Kun on otettu huomioon neuvoston 24 päivänä kesäkuuta 2005 antama lausuma ja kuultu uudestaan Euroopan elintarviketurvallisuusviranomaista, vaikuttaa siltä, että Zea mays L. linja T25 -tuotteen tieteellinen arviointi vahvistaa kolmannen kerran sen, että tuotteella ei todennäköisesti ole haittavaikutuksia ihmisten tai eläinten terveyteen taikka ympäristöön. Komissio katsoo tämän vuoksi, että ehdotusta ei olisi muutettava, ja se tekee ehdotuksensa neuvostolle uudelleen neuvoston päätöksen 1999/468/EY 5 artiklan 6 kohdan mukaisesti.EhdotusNEUVOSTON PÄÄTÖSbmuuntogeenisen maissin ( Zea mays L. linja T25) käytön ja myynnin väliaikaisesta kieltämisestä Itävallassa Euroopan parlamentin ja neuvoston direktiivin 2001/18/EY mukaisesti(Ainoastaan saksankielinen versio on todistusvoimainen (ETA:n kannalta merkityksellinen teksti)EUROOPAN UNIONIN NEUVOSTO, jokaottaa huomioon Euroopan yhteisön perustamissopimuksen,ottaa huomioon geneettisesti muunnettujen organismien tarkoituksellisesta levittämisestä ympäristöön ja neuvoston direktiivin 90/220/ETY kumoamisesta 12 päivänä maaliskuuta 2001 annetun Euroopan parlamentin ja neuvoston direktiivin 2001/18/EY[5] ja erityisesti sen 23 artiklan 2 kohdan,ottaa huomioon komission ehdotuksen,sekä katsoo seuraavaa:(1) Geneettisesti muunnetun maissin ( Zea mays L. linja T25) saattamisesta markkinoille neuvoston direktiivin 90/220/ETY mukaisesti 22 päivänä huhtikuuta 1998 tehdyssä komission päätöksessä 98/293/EY[6] säädetään, että kyseisen tuotteen markkinoille saattamiseen on annettava lupa.(2) Ranskan viranomaiset antoivat kyseisen luvan 3 päivänä elokuuta 1998.(3) Direktiivin 90/220/ETY korvanneen direktiivin 2001/18/EY[7] 35 artiklan 1 kohdan mukaan geneettisesti muunnettujen organismien markkinoille saattamista koskeviin ilmoituksiin, joiden osalta menettelyä ei ole saatettu päätökseen ennen 17 päivää lokakuuta 2002, sovelletaan direktiiviä 2001/18/EY.(4) Itävalta ilmoitti 8 päivänä toukokuuta 2000 komissiolle päätöksestään kieltää väliaikaisesti Zea mays L. linja T25 -tuotteen käyttö ja myynti sekä antoi syyt tähän direktiivin 90/220/ETY 16 artiklan 1 kohdan mukaisesti.(5) Kasveja käsittelevä tiedekomitea katsoi 20 päivänä heinäkuuta 2001, että Itävallan esittämät tiedot eivät sisällä sellaista uutta ja olennaista tieteellistä todistusaineistoa, jota ei olisi otettu huomioon asiaa alun perin arvioitaessa ja joka edellyttäisi komitean kyseisestä tuotteesta antaman alkuperäisen lausunnon tarkistamista.(6) Itävalta toimitti 9 päivänä tammikuuta 2004 sekä 9 ja 17 päivänä helmikuuta 2004 komissiolle lisätietoja linjan T25 maissia koskevien kansallisten toimenpiteidensä tueksi.(7) Komissio pyysi direktiivin 2001/18/EY 28 artiklan 1 kohdan mukaisesti lausuntoa Euroopan elintarviketurvallisuusviranomaiselta (EFSA), joka on perustettu Euroopan parlamentin ja neuvoston asetuksella (EY) N:o 178/2002[8] ja joka kyseisen asetuksen nojalla on korvannut asiaa käsittelevät tiedekomiteat.(8) Euroopan elintarviketurvallisuusviranomainen katsoi 8 päivänä heinäkuuta 2004[9], että Itävallan esittämät tiedot eivät sisällä sellaista uutta tieteellistä todistusaineistoa, joka riittäisi mitätöimään linjan T25 maissin ympäristöriskien arvioinnin ja antaisi tästä syystä oikeutuksen kyseisen tuotteen käytön ja myynnin kieltämiseen Itävallassa.(9) Koska silloisen tietämyksen perusteella ei ollut syytä epäillä tuotteen olevan vaaraksi ihmisten terveydelle tai ympäristölle, komissio toimitti 29 päivänä marraskuuta 2004 luonnoksen päätökseksi, jonka mukaan Itävallan olisi kumottava väliaikaiset suojalauseketoimenpiteensä, direktiivin 2001/18/EY 30 artiklan mukaisesti perustetun komitean harkittavaksi kyseisen direktiivin 30 artiklan 2 kohdassa tarkoitetun menettelyn mukaisesti.(10) Kyseinen komitea ei kuitenkaan antanut lausuntoa, ja menettelystä komissiolle siirrettyä täytäntöönpanovaltaa käytettäessä 28 päivänä kesäkuuta 1999 annetun neuvoston päätöksen 1999/468/EY[10] 5 artiklan 4 kohdan mukaisesti komissio toimitti neuvostolle ehdotuksen tarvittavista toimenpiteistä.(11) Neuvosto hylkäsi kuitenkin 24 päivänä kesäkuuta 2005 ehdotuksen määräenemmistöllä päätöksen 1999/468/EY 5 artiklan 6 kohdan mukaisesti.(12) Neuvosto totesi lausumassaan, että kyseisen muuntogeenisen maissilajikkeen T25 markkinoille saattamiseen liittyvästä kansallisesta suojatoimenpiteestä vallitsee edelleen tietynasteinen epävarmuus, ja kehotti komissiota hankkimaan lisää näyttöä kyseisestä muuntogeenisestä organismista sekä arvioimaan, onko kyseisen organismin markkinoille saattamisen väliaikainen lykkääminen oikeutettu varotoimenpide Itävallassa ja onko sen markkinoille saattamisen salliminen edelleen direktiivissä 2001/18/EY säädettyjen turvallisuusvaatimusten mukaista.(13) Marraskuussa 2005 Euroopan elintarviketurvallisuusviranomaista kuultiin uudestaan siitä, voidaanko tieteellisin perustein katsoa, että linjan T25 maissin markkinoille saattamisen jatkamisella on lupaehtoja noudatettaessa todennäköisesti haitallisia vaikutuksia ihmisten terveyteen tai ympäristöön[11]. Euroopan elintarviketurvallisuusviranomaista pyydettiin erityisesti ottamaan huomioon tieteelliset tiedot, joita oli mahdollisesti ilmaantunut sen aiemman tieteellisen lausunnon jälkeen, jossa oli arvioitu kyseisen muuntogeenisen organismin turvallisuutta.(14) Maaliskuun 29 päivänä 2006 antamassaan lausunnossa Euroopan elintarviketurvallisuusviranomainen totesi, ettei ollut syytä uskoa linjan T25 maissin markkinoille saattamisen jatkamisella lupaehtoja noudatettaessa olevan haittavaikutuksia ihmisten tai eläinten terveyteen taikka ympäristöön.(15) Sen vuoksi Itävallan tulisi kumota Zea mays L. linja T25 -tuotetta koskevat suojalauseketoimenpiteet,ON TEHNYT TÄMÄN PÄÄTÖKSEN:1 artiklaItävallan toteuttamat toimenpiteet muuntogeenisen maissin Zea mays L. linja T25, jonka markkinoille saattamiseen on annettu lupa päätöksellä 98/293/EY, käytön ja myynnin kieltämiseksi eivät ole oikeutettuja direktiivin 2001/18/EY 23 artiklan säännösten perusteella.2 artiklaItävallan on toteutettava tarvittavat toimenpiteet tämän päätöksen noudattamiseksi 20 päivän kuluessa päätöksen tiedoksi antamisesta.3 artiklaTämä päätös on osoitettu Itävallan tasavallalle.Tehty BrysselissäNeuvoston puolestaPuheenjohtaja [1] EYVL L 106, 17.4.2001, s. 1.[2] EYVL L 31, 1.2.2002, s. 1. Asetus sellaisena kuin se on viimeksi muutettuna komission asetuksella (EY) N:o 575/2006 (EUVL L 100, 8.4.2006, s. 3).[3] Opinion of the Scientific Panel on Genetically Modified Organisms on a request from the Commission related to the Austrian invoke of Article 23 of Directive 2001/18/EC, The EFSA Journal (2004) 78, 1-13.[4] Opinion of the Scientific Panel on Genetically Modified Organisms on a request from the Commission related to genetically modified crops (Bt176 maize, MON810 maize, T25 maize, Topas 19/2 oilseed rape and Ms1xRf1 oilseed rape) subject to safeguard clauses invoked according to Article 16 of Directive 90/220/EEC, The EFSA Journal (2006) 338, 1-15.[5] EYVL L 106, 17.4.2001, s. 1.[6] EYVL L 131, 5.5.1998, s. 30.[7] EYVL L 117, 8.5.1990, s. 15.[8] EYVL 31, 1.2.2002, s. 1. Asetus sellaisena kuin se on viimeksi muutettuna komission asetuksella (EY) N:o 575/2006 (EUVL L 100, 8.4.2006, s. 3).[9] Opinion of the Scientific Panel on Genetically Modified Organisms on a request from the Commission related to the Austrian invoke of Article 23 of Directive 2001/18/EC, The EFSA Journal (2004) 78, 1-13.[10] EYVL L 184, 17.7. 1999, s. 23.[11] Opinion of the Scientific Panel on Genetically Modified Organisms on a request from the Commission related to genetically modified crops (Bt176 maize, MON810 maize, T25 maize, Topas 19/2 oilseed rape and Ms1xRf1 oilseed rape) subject to safeguard clauses invoked according to Article 16 of Directive 90/220/EEC, The EFSA Journal (2006) 338, 1-15.


type: contracts

jurisdiction: EU

text:
 9.8.2007
 MT
 Il-Ġurnal Uffiċjali ta’ l-Unjoni Ewropea
 L 209/46
 DEĊIŻJONI TAL-KUMITAT KONĠUNT TAŻ-ŻEE
 Nru 26/2007
 tas-27 ta' April 2007
 li temenda l-Anness XIII (It-Trasport) tal-Ftehim dwar iż-ŻEE
 IL-KUMITAT KONĠUNT TAŻ-ŻEE,
 Wara li kkunsidra l-Ftehim dwar iż-Żona Ekonomika Ewropea, kif emendat bil-Protokoll li jaġġusta l-Ftehim dwar iż-Żona Ekonomika Ewropea, minn hawn 'il quddiem imsejjaħ ‘il-Ftehim’, u b'mod partikolari l-Artikolu 98 tiegħu,
 Billi:
 (1)
 L-Anness XIII tal-Ftehim ġie emendat bid-Deċiżjoni tal-Kumitat Konġunt taż-ŻEE Nru 155/2006 tat-8 ta' Diċembru 2006 (1).
 (2)
 Ir-Regolament (KE) Nru 2320/2002 tal-Parlament Ewropew u tal-Kunsill tas-16 ta' Diċembru 2002 jistabbilixxi regoli komuni fil-qasam tas-sigurtà ta' l-avjazzjoni ċivili (2) ġie inkorporat fil-Ftehim bid-Deċiżjoni tal-Kumitat Konġunt taż-ŻEE Nru 61/2004 tas-26 ta' April (3) b'adattamenti speċifiċi għall-pajjiż partikolari.
 (3)
 Ir-Regolament tal-Kummissjoni (KE) Nru 831/2006 tat-2 ta' Ġunju 2006 jemenda r-Regolament (KE) Nru 622/2003 li jistabbilixxi miżuri għall-implimentazzjoni ta' standards bażiċi komuni dwar is-sigurtà fl-avjazzjoni (4) għandu jiġi inkorporat fil-Ftehim,
 IDDEĊIEDA DAN LI ĠEJ:
 Artikolu 1
 L-inċiż li ġej għandu jiżdied mal-punt 66i (ir-Regolament tal-Kummissjoni (KEE) 622/2003) ta' l-Anness XIII tal-Ftehim:
 “—
 32006 R 0831: Ir-Regolament tal-Kummissjoni (KE) Nru. 831/2006 tat-2 ta' Ġunju 2006 (ĠU L 150, tat-3.6.2006, p. 4).”
 Artikolu 2
 It-testi tar-Regolament (KE) Nru 831/2006 fl-ilsien Iżlandiż u l-ilsien Norveġiż, li ser jiġu ppubblikati fis-Suppliment ŻEE tal-Ġurnal Uffiċjali tal-Unjoni Ewropea, għandhom ikunu awtentiċi.
 Artikolu 3
 Din id-Deċiżjoni għandha tidħol fis-seħħ fit-28 ta' April 2007, sakemm ikunu saru n-notifiki kollha taħt l-Artikolu 103(1) tal-Ftehim lill-Kumitat Konġunt taż-ŻEE (*).
 Artikolu 4
 Din id-Deċiżjoni għandha tiġi ppublikata fis-Sezzjoni ŻEE u fis-Suppliment ŻEE tal-Ġurnal Uffiċjali ta' l-Unjoni Ewropea.
 Magħmul fi Brussell, 27 ta' April 2007.
 Għall-Kumitat Konġunt taż-ŻEE
 Il-President
 Alan SEATTER
 (1) ĠU L 89, 29.3.2007, p. 29.
 (2) ĠU L 355, 30.12.2002, p. 1.
 (3) ĠU L 277, 26.8.2004, p. 175.
 (4) ĠU L 150, 3.6.2006, p. 4.
 (*) Ebda obbligi kostituzzjonali m'huma indikati.


type: caselaw

text:
 23.6.2012
 PT
 Jornal Oficial da União Europeia
 C 184/22
 Recurso interposto em 11 de janeiro de 2012 — ZZ/Comissão Europeia
 (Processo F-6/12)
 2012/C 184/46
 Língua do processo: francês
 Partes
 Recorrente: ZZ (Representante: C. Dony, advogado)
 Recorrida: Comissão Europeia
 Objeto e descrição do litígio
 Anulação da decisão da Comissão que indefere a reclamação do recorrente da decisão que lhe recusa o benefício do subsídio de expatriação.
 Pedidos do recorrente
 —
 Anulação da decisão da AIPN de 11 de outubro de 2011, que indefere a reclamação do recorrente nos termos do artigo 90.o, n.o 2, do Estatuto, da decisão de 24 de maio de 2011 que lhe recusa o benefício do subsídio de expatriação.
 —
 Condenação da Comissão Europeia nas despesas.


type: wikipedia

text:
En almindelig kåre (Neomysis integer) er et krebsdyr i gruppen pungrejer, der er knap 2 cm lang. Den er meget almindelig ved de fleste af vores kyster. Den findes på lavt vand i beskyttede områder. Som de fleste andre kårer svømmer den frit i vandet i store stimer. Den kan ligne en "rejeunge", men kendes på sine stilkede øjne og sin svømmevifte. Kåren lever af alger og larver af rejer, krabber og børsteorme.
 Kilder/Henvisninger
 Mandahl-Barth, Skytte Christiansen, Østergaard. Hvad finder jeg på stranden, side 111. Politikens Forlag. 12. udgave 1986.
 Storkrebs


text:
John Rissler "Jack" Messer (né le ) est un fermier et un homme politique provincial canadien de la Saskatchewan. Il représente les circonscriptions de Kelsey, Tisdale-Kelsey et de Kelsey-Tisdale à titre député du Nouveau Parti démocratique de 1967 à 1980.
 Biographie
 Né à Tisdale en Saskatchewan, Messer étudie à Vancouver en Colombie-Britannique. Travaillant comme agent d'immeuble dans cette ville, il poursuit ses études à l'Université de la Colombie-Britannique et à l'Université de la Saskatchewan. S'établissant à Tisdale, il s'installe sur une ferme. Épousant la fille de Hugh Alexander Bryson, député CCF de Humboldt—Melfort de 1953 à 1958, il devient secrétaire de la Tisdale Wheat Pool Committee et directeur de la Evington Rural Telephone Company.
 Élu en 1967, il sert dans le cabinet à titre de ministe de l'Agriculture, ministre de l'Industrie et Commercer et ministre des Ressources minérales. Il démissionne de ses fonctions ministérielles et du poste de député en 1980.
 En 1990, il devient secrétaire provincial du Nouveau Parti démocratique de la Saskatchewan. Président de SaskPower de 1991 à 1998, il devient ensuite directeur de Canards Illimités de 2002 à 2004.
 Résultats électoraux
 Références
 Liens externes
 Naissance en mai 1941
 Membre du Conseil exécutif de la Saskatchewan
 Député du Nouveau Parti démocratique de la Saskatchewan
 Étudiant de l'Université de la Colombie-Britannique
 Étudiant de l'Université de la Saskatchewan


text:
 15.12.2014
 DE
 Amtsblatt der Europäischen Union
 C 448/13
 Vorabentscheidungsersuchen des Centrale Raad van Beroep (Niederlande), eingereicht am 9. Oktober 2014 — Raad van bestuur van de Sociale verzekeringsbank/F. Wieland und H. Rothwangl
 (Rechtssache C-465/14)
 (2014/C 448/17)
 Verfahrenssprache: Niederländisch
 Vorlegendes Gericht
 Centrale Raad van Beroep
 Parteien des Ausgangsverfahrens
 Rechtsmittelführer: Raad van bestuur van de Sociale verzekeringsbank
 Rechtsmittelgegner: F. Wieland und H. Rothwangl
 Vorlagefragen
 1.
 Sind die Art. 3 sowie 94 Abs. 1 und 2 der Verordnung Nr. 1408/71 (1) dahin auszulegen, dass einem ehemaligen Seemann, der zur Besatzung eines Seeschiffs mit einem Heimathafen in einem Mitgliedstaat gehörte, keinen Wohnsitz an Land hatte und nicht die Staatsangehörigkeit eines Mitgliedstaats besaß, nach dem Beitritt des Staates, dessen Staatsangehörigkeit dieser Seemann besitzt, zur Union (bzw. zu einer Rechtsvorgängerin der Union) oder nach Inkrafttreten der Verordnung Nr. 1408/71 für diesen Staat nicht allein deshalb eine Altersrente (teilweise) verweigert werden darf, weil der genannte ehemalige Seemann zur Zeit einer (beanspruchten) Versicherung nicht im Besitz der Staatsangehörigkeit des (erstgenannten) Mitgliedstaats war?
 2.
 Sind die Art. 18 AEUV und 45 AEUV dahin auszulegen, dass sie einer Regelung eines Mitgliedstaats entgegenstehen, wonach ein Seemann, der zur Besatzung eines Seeschiffs mit einem Heimathafen in diesem Mitgliedstaat gehörte, keinen Wohnsitz an Land hatte und nicht die Staatsangehörigkeit eines Mitgliedstaats besaß, von der Altersrentenversicherung ausgeschlossen war, während nach dieser Regelung ein Seemann als versichert gilt, der Staatsangehöriger des Mitgliedstaats ist, in dem das Seeschiff seinen Heimathafen hat, und sich im Übrigen in der gleichen Situation befindet, wenn der Staat, dessen Staatsangehöriger der erstgenannte Seemann ist, inzwischen — zum Zeitpunkt der Feststellung der Rente — (einer Rechtsvorgängerin) der Union beigetreten oder die Verordnung Nr. 1408/71 inzwischen für diesen Staat in Kraft getreten ist?
 3.
 Sind die Fragen 1 und 2 im Fall eines (ehemaligen) Seemanns, der zur Zeit seiner Tätigkeiten die Staatsangehörigkeit eines Staates besaß, der zu einem späteren Zeitpunkt (einer Rechtsvorgängerin) der Union beitritt, zur Zeit dieses Beitritts oder des Inkrafttretens der Verordnung Nr. 1408/71 für den erwähnten Staat und zur Zeit der Geltendmachung seines Anspruchs auf eine Altersrente jedoch nicht Staatsangehöriger eines Mitgliedstaats ist, auf den die letztgenannte Verordnung gemäß Art. 1 der Verordnung Nr. 859/2003 (2) aber dennoch Anwendung findet, genauso zu beantworten?
 (1) Verordnung (EWG) Nr. 1408/71 des Rates vom 14. Juni 1971 zur Anwendung der Systeme der sozialen Sicherheit auf Arbeitnehmer und deren Familien, die innerhalb der Gemeinschaft zu- und abwandern (ABl. L 149, S. 2).
 (2) Verordnung (EG) Nr. 859/2003 des Rates vom 14. Mai 2003 zur Ausdehnung der Bestimmungen der Verordnung (EWG) Nr. 1408/71 und der Verordnung (EWG) Nr. 574/72 auf Drittstaatsangehörige, die ausschließlich aufgrund ihrer Staatsangehörigkeit nicht bereits unter diese Bestimmungen fallen (ABl. L 124, S. 1).


text:
Mansnamnet Ulf är ett fornnordiskt namn med betydelsen varg, jfr ulv.
 Äldsta belägg i Sverige är runinskrift på 1000-talet, ex. på stenen i Källby hallar, Västergötland. Ulf och Ragnar, de båda reste denna sten efter Fare, sin fader ... kristen man. Han hade god tro på Gud.
 Traditionellt uttalades namnet Ulv, men efter stavningsreformen 1906 (då v-ljudet kom att konsekvent stavas med v, utom i egennamn) har läsuttalet med f efterhand blivit helt gällande, på samma sätt som hos namn som Alf och Olof.
 Ulf är relativt vanligt bland män mellan 30 och 60 år, men används numera mest som andranamn. 31 december 2015 fanns det totalt 64 409 män med namnet Ulf i Sverige, 34 072 hade det som tilltalsnamn.
 År 2003 fick 196 pojkar namnet, varav 4 fick det som tilltalsnamn. Ännu 2010 var det färre än 10 nyfödda som fick det som tilltalsnamn. Uffe är ett vanligt smeknamn.
 Namnsdag i Sverige: 11 april, delas med Ylva. Ylva är den kvinnliga motsvarigheten till namnet, det betyder alltså vargtik.
 Personer med förnamnet Ulf
 A-G
 Ulf Adelsohn, svensk politiker, före detta ledare för moderata samlingspartiet, statsråd och landshövding i Stockholms län
 Ulf Andersson, svensk schackspelare
 Ulf Bjereld, professor i statskunskap
 Ulf Björlin, kompositör och dirigent
 Ulf Brunnberg, svensk skådespelare
 Ulf Dageby, svensk kompositör och musiker
 Ulf Dahlén, svensk ishockeyspelare
 Ulf Dahlsten, svensk ämbetsman och företagsledare
 Ulf Danielsson, professor, dekanus, vicerektor vid Uppsala universitet
 Ulf Ekberg, svensk popmusiker
 Ulf Ekman, svensk pastor, f.d. ledare för Livets Ord
 Ulf Elfving, svensk journalist, känd radioman
 Uffe Ellemann-Jensen, dansk politiker (Venstre), utrikesminister 1982-1993.
 Ulf Eriksson, svensk fotbollsspelare
 Ulf von Euler, svensk fysiolog och nobelpristagare
 Ulf Fase, svensk jarl under medeltiden
 Ulf Friberg, svensk skådespelare
 Ulf Granberg, svensk motorsportare
 Ulf Granberg, svensk serieredaktör och serieskapare
 Ulf Gärdenfors, professor i naturvårdsbiologi
 H-N
 Ulf Högberg, svensk medeldistanslöpare
 Ulf Jarfelt, svensk längdhoppare
 Ulf Johanson, svensk skådespelare
 Ulf Karlsson, friidrottsledare
 Ulf Kirsten, tysk fotbollsspelare
 Ulf Kristersson, svensk politiker (M), statsråd, partiledare
 Ulf Kvensler, svensk komiker och manusförfattare
 Ulf Larsson, svensk skådespelare och TV-programledare
 Ulf Linde, konstkritiker, jazzmusiker, författare, m.m., ledamot av Svenska Akademien
 Ulf Lundell, svensk författare och rockmusiker
 Ulf Lundkvist, svensk serieskapare och konstnär
 Ulf Lundmark, sångare
 Ulf Lundstedt, svensk långdistanslöpare
 Ulf Lönnqvist, f.d. statsråd, f.d. landshövding i Blekinge län
 Ulf Malmros, filmregissör och manusförfattare
 Ulf Melin, generaldirektör
 Ulf Merbold, tysk ESA-astronaut
 Ulf Nilson, svensk journalist
 Ulf Nilsson (författare), svensk journalist
 Ulf Nilsson (ishockeyspelare) ("Lill-Pröjsarn"), svensk ishockeyspelare
 Ulf Nyberg, skådespelare och musiker
 O-W
 Ulf Peder Olrog, svensk artist och kompositör
 Ulf Olsson, svensk mördare
 Ulf Ottosson, svensk fotbollsspelare, "Mål-Otto"
 Ulf Palme, skådespelare och regissör
 Ulf Qvarsebo, svensk skådespelare
 Ulf Rahmberg, svensk konstnär
 Ulf Samuelsson, ishockeyspelare
 Ulf Schefvert, svensk handbollsspelare
 Ulf Schenkmanis, svensk journalist, radio- och TV-profil
 Ulf Schmidt, svensk tennisspelare
 Ulf Sedlacek, svensk häcklöpare
 Ulf Sjöstedt, svensk fotograf och författare
 Ulf Stark, svensk författare
 Ulf Stenlund, svensk tennisspelare
 Ulf Sterner, svensk ishockeyspelare
 Ulf Sundelin, tävlingsseglare (5,5 meter), OS-guldmedaljör
 Ulf Sundqvist, finländsk politiker
 Ulf Söderblom, finländsk dirigent och musikprofessor
 Ulf Söderman, svensk häcklöpare och sprinter
 Ulf Thorén, journalist
 Ulf Timmermann, östtysk friidrottare
 Ulf Trotzig, svensk konstnär
 Ulf Wickbom, journalist
 Referenser
 Mansnamn
 Svenska förnamn
 Svenska mansnamn
 Fornnordiska mansnamn


text:
Inovácija ali novost, nov pojav, je lahko nova zamisel, nov proizvodni ali tehnološki postopek, nov izdelek ali predmet z novimi funkcijami. Inovacija se od invencije (izuma) razlikuje v komercializaciji. Inovacija je torej uspešno sprejeta na trgu. Inovacija prinaša novo, večjo uporabnost v obliki dviga kakovosti, nižanja stroškov, dviganja ugleda podjetja, omejevanja konkurence ipd.
 Vse sodobne družbe z razvitim gospodarstvom si prizadevajo, da imajo čim več inovacij, zato v te namene investirajo velika finančna sredstva. Moč držav se danes meri tudi po številu prijavljenih, še bolj pa uporabljenih inovacij. Slovenija je žal na repu teh držav.
 Organiziranje inovacijske dejavnosti v Sloveniji
 Razvoj inovacij v Sloveniji se je organizirano pričel po letu 1955, ko je bil glavni namen spodbujanja inovacij povečati produktivnost gospodarstva. Leta 1979 so celo organizirali posvetovanje na zvezni ravni o planiranju inovacijske dejavnosti, kar je bilo tudi realizirano v srednjeročnem planu razvoja od leta 1981 do 1985. To je sprožilo množično inovativno dejavnost na vseh ravneh. Inovativno dejavnost so pričeli načrtovati v velikih gospodarskih sistemih, predvsem proizvodnih. Žal so imeli neposredni inovatorji vseskozi težave z ocenami komisij o njihovem prispevku k inovaciji, kakor tudi s konkretnim finančnim, včasih pa tudi moralnim nagrajevanjem inovacij. Problemi so nastajali tudi takrat, ko določene inovacije niso dajale pričakovanih rezultatov, sledili so spori in slaba volja.
 Po letu 1985 je bila na tem področju zelo aktivna VEKŠ Maribor z dr. Matjažem Mulejem na čelu. V teoriji in praksi je razvila metodo USOMID. Ta je začela dajati prve kvalitetne rezultate v slovenski industriji, žal pa je bila leta 1992, po razpadu Jugoslavije, ukinjena.
 Inovacije zahtevajo določena finančna sredstva, čeprav jih dajo inovatorji - kar ni verjetno - zastonj.
 Razmerja vlaganj pa se na Slovenskem in drugod obnašajo takole:
 zamisel ali temeljna raziskava - zahteva 1x finančna enota,
 raziskava uporabnosti - zahteva 10x finančna enota,
 razvoj-poskusna proizvodnja - zahteva 100x finančna enota,
 Tu se pa pričnejo težave, nekdo mora zagotoviti sredstva - rizični kapital ali tvegani kapital, kateri ima svoje zakonitosti pridobivanja in vlaganja. Tudi tvegani kapital išče svoj dobiček, vendar pa se veže le na srednjeročne in dolgoročne naložbe po pravilu- 2:6:2 ali od desetih naložb v inovacije so 2 zelo uspešne, 6 je povprečnih in 2 prinašajo izgubo.
 Organiziranje inovacijske dejavnosti v industrijskih podjetjih ZDA
 Organizirano zbiranje inovacijskih predlogov za povečanje efektov dela v ZDA se je pričelo že leta 1880, ko je Yale and Towne manufacturing Company uvedla zbiranje inovatorskih predlogov in o tem obstajajo pismeni podatki. Od tega leta dalje v ZDA zanimanje za sisteme inovacijskih predlogov samo narašča in v letu 1968 je bilo registriranih preko 6000 inovacij po katerih so delali v več kot 10000 tovarnah v ZDA. V istem letu je v podjetju General Motors bilo izplačano inovatorjem za skupno število 247.109 predlogov 14.295.387 dolarjev nagrad, podjetju pa so prinesle ogromno korist. Takšen način zbiranja inovacijskih predlogov se je na zahodu nadaljeval tudi v 20. stoletju, efekti dela pa so bili vse večji. Iz ZDA so se takšni sistemi pričeli širiti tudi v Evropo.
 (Vir: Annual Statistical Report, National Association of Suggestion Systems, Chicago, 1968.)
 V drugi polovici 70. let 20. stoletja, je v velikih zahodnih kapitalističnih podjetjih bila organizirana množična inovativna dejavnost. Tako so v znanih svetovnih podjetjih dosegli prijavljanje številnih inovacij. Obstajajo podatki o prijavljenih inovacijah za podjetja, kot sledi;
 Honeywell Inc. - 178 predlogov na 100 zaposlenih,
 Control Data - 105 predlogov na 100 zaposlenih,
 General Motors Corp. - 84 predlogov na 100 zaposlenih,
 Firestone Tire RBR Co. - 69 predlogov na 100 zaposlenih, približno istočasno je v Sloveniji potekala akcija prijavljanja predlogov za inovacije v mariborskem območju v velikih delovnih organizacijah, kot so:
 Elektrokovina,
 Tovarna stikalnih naprav,
 Marles,
 Tovarna avtomobilov Maribor, kjer kljub dobri organizaciji niso uspeli pridobiti več od 1 do 4 predloge inovacij na 100 zaposlenih. To pokaže, da je treba inovativnost gojiti in organizirati, ker ni samoumevna, odvisna je predvsem od posameznikov, ki sodelujejo v proizvodnem procesu.
 Vložitev prijave za pridobitev patenta za inovacijo
 Vložitev prijave za pridobitev patenta je nujna za inovatorja, zaradi zaščite intelektualne lastnine, še preden pride izdelek/storitev na trg. To je pomembno za dolgoročni razvoj podjetja, ki bo izdelek/storitev delal in tržil. Po vložitvi prijave za pridobitev patenta mora inovator začeti s krepko bitko za pridobitev patenta, saj bo moral brskati med celo goro podobnih izumov, pri tem je pametno uporabljati domače strokovnjake, ker bodo najcenejši in se zelo dobro spoznajo na tehnični jezik,- strokovno latovščino.
 Inovacijski proces
 Inovacijski proces je proces, skozi katerega gre inovacija od ideje do inovacije, ki se je potrdila na trgu.
 Zamisel ali ideja je rezultat najvišje umske dejavnosti, ki nakazuje uresničitev ali izvedbo česa. Je zamisel. Ideja (še) ne rešuje problema niti ne pomeni, da je to pravi korak do rešitve določenega problema.
 Iznajdba ali invencija je nova zamisel, ki je obetavna in rešuje problem ali nerešeno potrebo, ni nujno pa da se v prihodnosti izkaže kot uporabna. Je rezultat raziskovalnega dela. Nanaša se lahko na nov proizvod, storitev, proces ali sistem. Možna je zaščita in trženje pravice intelektualne lastnine, če je tehnično izvedljiva in funkcionalna.
 Potencialna inovacija je do uporabnosti dognana invencija, ki pa še ni dala nove koristi, ki bi bila potrjena na trgu. Je rezultat razvoja, ki se pojavi v obliki izdelave prototipa ali uspešno izvedene poskusne proizvodnje. Možna je zaščita in trženje pravice intelektualne lastnine, npr. patenta, preden je proizvod skomercializiran.
 Inovacija je uporabna novost, katere koristnost se je potrdila na trgu. Prinaša novo, večjo uporabnost v obliki dviga kakovosti, nižanja stroškov, dviganja ugleda podjetja, omejevanja konkurence itn. Je rezultat razvojno-raziskovalnega dela pri katerem je za realizacijo na trgu potreben celovit poslovni pristop.
 Glej tudi
 TRIZ
 Zunanje povezave
 Slovenski forum inovacij-
 Innovation Tools (v angleščini)
 Inovacije za učence, študente, diplomante
 Financiranje inovacij
 Stran aktivnih inovatorjev Slovenije-
 Kako zaščititi inovacije?-
 Portal za inovativne Imam idejo!
 Slovenski urad za intelektualno lastnino-
 Evropski urad za patente-
 Urad EU za harmonizacijo notranjega trga-
 Svetovna organizacija za intelektualno lastnino-
 EVCA-Evropsko združenje za tvegani kapital-Venture Capital
 Portal Od Ideje Do Izvedbe
 Oblikovanje
 Ustvarjalnost
 Gospodarski razvoj
 Poslovna ekonomija
 Produktni menedžment
 Tehnologija
 Zgodovina tehnike


text:
 13.4.2012
 EN
 Official Journal of the European Union
 L 103/51
 DECISION No 1/2012 OF THE JOINT COMMITTEE ESTABLISHED UNDER THE AGREEMENT BETWEEN THE EUROPEAN COMMUNITY AND ITS MEMBER STATES, OF THE ONE PART, AND THE SWISS CONFEDERATION, OF THE OTHER, ON THE FREE MOVEMENT OF PERSONS
 of 31 March 2012
 replacing Annex II to that Agreement on the coordination of social security schemes
 (2012/195/EU)
 THE JOINT COMMITTEE,
 Having regard to the Agreement between the European Community and its Member States, of the one part, and the Swiss Confederation, of the other, on the free movement of persons (1) (‘the Agreement’), and in particular Article 18 thereof,
 Whereas:
 (1)
 The Agreement was signed on 21 June 1999 and entered into force on 1 June 2002.
 (2)
 Annex II to the Agreement on the coordination of social security schemes was last amended by Decision No 1/2006 of the EU-Swiss Joint Committee (2) and should now be updated to take account of the new legal acts of the European Union that have entered into force since then, in particular Regulation (EC) No 883/2004 of the European Parliament and of the Council of 29 April 2004 on the coordination of social security systems (3) and the measures adopted to implement that Regulation.
 (3)
 Regulation (EC) No 883/2004 has replaced Council Regulation (EEC) No 1408/71 of 14 June 1971 on the application of social security schemes to employed persons, to self-employed persons and to members of their families moving within the Community (4).
 (4)
 In the interests of clarity and rationality, Annex II to the Agreement and the Protocol to that Annex should be consolidated in a legally binding version.
 (5)
 Annex II to the Agreement should be maintained in line with the evolution of the relevant legal acts of the European Union,
 HAS ADOPTED THIS DECISION:
 Article 1
 Annex II to the Agreement between the European Community and its Member States, of the one part, and the Swiss Confederation, of the other, on the free movement of persons (‘the Agreement’) is replaced by the Annex to this Decision.
 Article 2
 This Decision is established in the Bulgarian, Czech, Danish, Dutch, English, Estonian, Finnish, French, German, Greek, Hungarian, Italian, Latvian, Lithuanian, Maltese, Polish, Portuguese, Romanian, Slovak, Slovenian, Spanish and Swedish languages, the texts in each of these languages being equally authentic.
 Article 3
 The Decision shall enter into force on the day following the day of its adoption.
 Done at Brussels, 31 March 2012.
 For the Joint Committee
 The Chairman
 Mario GATTIKER
 (1) OJ L 114, 30.4.2002, p. 6.
 (2) OJ L 270, 29.9.2006, p. 67.
 (3) OJ L 166, 30.4.2004, p. 1.
 (4) OJ L 149, 5.7.1971, p. 2.
 ANNEX
 ‘
 ANNEX II
 CO-ORDINATION OF SOCIAL SECURITY SCHEMES
 Article 1
 1. The contracting parties agree, with regard to the coordination of social security schemes, to apply among themselves the legal acts of the European Union to which reference is made in, and as amended by, section A of this Annex, or rules equivalent to such acts.
 2. The term “Member State(s)” contained in the legal acts referred to in section A of this Annex shall be understood to include Switzerland in addition to the States covered by the relevant legal acts of the European Union.
 Article 2
 1. For the purposes of applying the provisions of this Annex, the contracting parties shall take into due account the legal acts of the European Union referred to in section B of this Annex.
 2. For the purposes of applying the provisions of this Annex, the contracting parties shall take note of the legal acts of the European Union referred to in section C of this Annex.
 Article 3
 1. Special provisions concerning the transitory arrangements relating to unemployment insurance for nationals of certain Member States of the European Union holding a Swiss residence permit valid for less than one year, concerning the Swiss allowances for helpless persons and concerning benefits under the occupational benefit plans regarding old-age, survivors’ and invalidity pensions are set out in the Protocol to this Annex.
 2. The Protocol forms an integral part of this Annex.
 SECTION A: LEGAL ACTS REFERRED TO
 (1)
 Regulation (EC) No 883/2004 of the European Parliament and of the Council of 29 April 2004 on the coordination of social security systems (1), as amended by Regulation (EC) No 988/2009 of the European Parliament and of the Council of 16 September 2009 amending Regulation (EC) No 883/2004 on the coordination of social security systems, and determining the content of its Annexes (2)
 For the purposes of this Agreement, Regulation (EC) No 883/2004 shall be adapted as follows:
 (a)
 the following shall be added to Annex I, section I:
 “Switzerland
 Cantonal legislation concerning the advances of maintenance payments based on Articles 131 paragraph 2 and 293 paragraph 2 of the Federal Civil Act.”;
 (b)
 the following shall be added to Annex I, section II:
 “Switzerland
 Birth grants and adoption grants pursuant to the relevant cantonal legislation based on Article 3 paragraph 2 of the Federal Family Allowances Act.”;
 (c)
 the following shall be added to Annex II:
 “Germany-Switzerland
 (a)
 Convention on social security of 25 February 1964, as amended by Complementary Conventions No 1 of 9 September 1975 and No 2 of 2 March 1989:
 (i)
 point 9b, paragraph 1, Nos 1-4 of the Final Protocol (legislation applicable and entitlement to sickness benefits in kind for residents of the German exclave of Büsingen);
 (ii)
 point 9e, paragraph 1(b), first, second and fourth sentences, of the Final Protocol (access to voluntary sickness insurance in Germany by relocation in Germany).
 (b)
 Convention on unemployment insurance of 20 October 1982, as amended by the Additional Protocol of 22 December 1992:
 (i)
 Article 8(5), Germany (district of Büsingen) shall contribute a sum equivalent to the cantonal contribution under Swiss law towards the cost of actual places on employment-promotion measures for workers subject to this provision.
 Spain-Switzerland
 Point 17 of the Final Protocol to the Convention on social security of 13 October 1969, as amended by the Complementary Convention of 11 June 1982; persons insured under the Spanish scheme by virtue of this provision are exempted from the requirement to join the Swiss sickness insurance scheme.
 Italy-Switzerland
 Article 9(1) of the Convention on social security of 14 December 1962, as amended by Complementary Convention No 1 of 18 December 1963, the Complementary Agreement of 4 July 1969, the Additional Protocol of 25 February 1974 and Complementary Agreement No 2 of 2 April 1980.”;
 (d)
 the following shall be added to Annex IV:
 “Switzerland”;
 (e)
 the following shall be added to Annex VIII, part 1:
 “Switzerland
 All claims for old-age, survivors’ and invalidity pensions under the basic scheme (Federal Law on old-age and survivors’ insurance and Federal Law on invalidity insurance) and statutory old-age pensions under the statutory occupational benefit plans (Federal Law on occupational benefit plans for old-age, survivors’ and invalidity insurance).”;
 (f)
 the following shall be added to Annex VIII, part 2:
 “Switzerland
 Old-age, survivors’ and invalidity pensions under the statutory occupational benefit plans (Federal Law on occupational benefit plans for old-age, survivors’ and invalidity insurance).”;
 (g)
 the following shall be added to Annex IX, part II:
 “Switzerland
 Survivors’ and invalidity pensions under the statutory occupational benefit plans (Federal Law on occupational benefit plans for old-age, survivors’ and invalidity insurance).”;
 (h)
 the following shall be added to Annex X:
 “Switzerland
 1.
 Supplementary benefits (Federal Supplementary Benefits Act of 19 March 1965) and similar benefits provided for under cantonal legislation.
 2.
 Pensions in the case of hardship under invalidity insurance (Article 28 subparagraph 1a of the Federal Invalidity Insurance Act of 19 June 1959, as amended on 7 October 1994).
 3.
 Non-contributory mixed benefits in the event of unemployment, as provided for under cantonal legislation.
 4.
 Non-contributory extraordinary invalidity pensions for disabled persons (Article 39 of the Federal Invalidity Insurance Act of 19 June 1959) who have not been subject, before their incapacity for work, to the Swiss legislation on the basis of an activity as an employed or self-employed person.”;
 (i)
 the following shall be added to Annex XI:
 “Switzerland
 1.
 Article 2 of the Federal Old-Age and Survivors’ Insurance Act and Article 1 of the Federal Invalidity Insurance Act, which govern voluntary insurance in these insurance branches for Swiss nationals resident in States not subject to this Agreement, shall be applicable to persons resident outside Switzerland who are nationals of the other States to which this Agreement applies, and to refugees and stateless persons resident in the territory of these States, where these persons join the voluntary insurance scheme not later than one year after the date on which they ceased to be covered by old-age, survivors’ and invalidity insurance after a continuous period of insurance of at least five years.
 2.
 Where a person ceases to be insured under Swiss old-age, survivors’ and invalidity insurance after a continuous period of insurance of at least five years, he shall continue to be entitled to be insured with the agreement of the employer if he works in a State to which this Agreement does not apply for an employer in Switzerland and if he submits an application to this effect within six months of the date on which he ceases to be insured.
 3.
 Compulsory insurance under Swiss sickness insurance and possible exemptions
 (a)
 The Swiss legal provisions governing compulsory sickness insurance shall apply to the following persons not resident in Switzerland:
 (i)
 persons subject to Swiss legal provisions under Title II of the Regulation;
 (ii)
 persons for whom Switzerland shall bear the costs of benefits according to Articles 24, 25, 26 of the Regulation;
 (iii)
 persons receiving Swiss unemployment insurance benefits;
 (iv)
 family members of persons referred to in (i) and (iii) or of an employed or self-employed person resident in Switzerland who is insured under the Swiss sickness insurance scheme, unless these family members are resident in one of the following States: Denmark, Spain, Hungary, Portugal, Sweden or the United Kingdom;
 (v)
 family members of persons referred to in (ii) or of a pensioner resident in Switzerland who is insured under the Swiss sickness insurance scheme, unless these family members are resident in one of the following States: Denmark, Portugal, Sweden or the United Kingdom.
 As family members are considered those persons who are defined as family members according to the legislation of the state of residence.
 (b)
 Persons referred to in (a) may, on request, be exempted from compulsory insurance if and as long as they are resident in one of the following States and can prove that they are eligible for cover in the event of sickness: Germany, France, Italy, Austria, and, with regard to persons referred to in (a) (iv) and (v), Finland and, with regard to persons referred to in (a)(ii), Portugal.
 This request
 (aa)
 must be submitted within three months of the date on which the obligation to take out insurance in Switzerland comes into effect; where, in justified cases, the request is submitted after this deadline, the exemption shall take effect as from the commencement of the insurance obligation;
 (bb)
 shall apply to all family members residing in the same State.
 4.
 Where a person subject to Swiss legal provisions under Title II of the Regulation is, in application of 3(b), subject for the purposes of sickness insurance to the legal provisions of another State covered by this Agreement, the costs of these benefits in kind for non-occupational accidents shall be shared equally between the Swiss insurer against occupational and non-occupational accidents and industrial diseases and the competent sickness insurance institution if an entitlement exists to benefits in kind from both bodies. The Swiss insurer against occupational and non-occupational accidents and industrial diseases shall meet all costs in the event of occupational accidents, accidents on the way to work or industrial diseases, even where there is an entitlement to benefits from a sickness insurance body in the country of residence.
 5.
 Persons who are working, but not residing in Switzerland and who have statutory insurance cover in their State of residence in accordance with point 3(b), as well as their family members, shall benefit from the provisions of Article 19 of the Regulation during a stay in Switzerland.
 6.
 For the purposes of applying Articles 18, 19, 20, 27 of the Regulation in Switzerland, the competent insurer shall bear all invoiced costs.
 7.
 Periods of daily allowance insurance completed under the insurance scheme of another State to which this Agreement applies shall be taken into account for reducing or lifting a possible reserve in daily allowance insurance in the event of maternity or sickness where the person becomes insured with a Swiss insurer within three months of ceasing to be covered by insurance in another country.
 8.
 Where a person who was gainfully employed or self-employed in Switzerland and covering his vital needs has had to cease his activity owing to an accident or illness and is no longer subject to Swiss legislation on invalidity insurance, he shall be considered to be covered by that insurance for the purpose of eligibility for rehabilitation measures until the payment of an invalidity pension and throughout the period during which he benefits from these measures, provided that he has not taken up a new activity outside Switzerland.”.
 (2)
 Regulation (EC) No 987/2009 of the European Parliament and of the Council of 16 September 2009 laying down the procedure for implementing Regulation (EC) No 883/2004 on the coordination of social security systems (3)
 For the purposes of this Agreement, Regulation (EC) No 987/2009 shall be adapted as follows:
 The following shall be added to Annex 1:
 “Arrangement between Switzerland and France of 26 October 2004 fixing the special procedures for the reimbursement of health care benefits
 Arrangement between Switzerland and Italy of 20 December 2005 fixing the special procedures for the reimbursement of health care benefits”.
 (3)
 Council Regulation (EEC) No 1408/71 of 14 June 1971 on the application of social security schemes to employed persons, to self-employed persons and to the members of their families moving within the Community (4), as last amended by Regulation (EC) No 592/2008 of the European Parliament and of the Council (5), as applicable between Switzerland and the Member States before the entry into force of this Decision, and when referred to in Regulation (EC) No 883/2004 or (EC) No 987/2009 or when cases are concerned which occurred in the past.
 (4)
 Council Regulation (EEC) No 574/72 of 21 March 1972 laying down the procedure for implementing Regulation (EEC) No 1408/71 on the application of social security schemes to employed persons, to self-employed persons and to the members of their families moving within the Community (6), as last amended by Commission Regulation (EC) No 120/2009 (7), as applicable between Switzerland and the Member States before the entry into force of this Decision, and when referred to in Regulation (EC) No 883/2004 or (EC) No 987/2009 or when cases are concerned which occurred in the past.
 (5)
 Council Directive 98/49/EC of 29 June 1998 on safeguarding the supplementary pension rights of employed and self-employed persons moving within the Community (8).
 SECTION B: LEGAL ACTS OF WHICH THE CONTRACTING PARTIES SHALL TAKE DUE ACCOUNT
 (1)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No A1 of 12 June 2009 concerning the establishment of a dialogue and conciliation procedure concerning the validity of documents, the determination of the applicable legislation and the provision of benefits under Regulation (EC) No 883/2004 of the European Parliament and of the Council (9).
 (2)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No A2 of 12 June 2009 concerning the interpretation of Article 12 of Regulation (EC) No 883/2004 of the European Parliament and of the Council on the legislation applicable to posted workers and self-employed workers temporarily working outside the competent State (10).
 (3)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No A3 of 17 December 2009 concerning the aggregation of uninterrupted posting periods completed under the Council Regulation (EEC) No 1408/71 and Regulation (EC) No 883/2004 of the European Parliament and of the Council (11).
 (4)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No E1 of 12 June 2009 concerning the practical arrangements for the transitional period for the data exchange via electronic means referred to in Article 4 of Regulation (EC) No 987/2009 of the European Parliament and of the Council (12).
 (5)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No F1 of 12 June 2009 concerning the interpretation of Article 68 of Regulation (EC) No 883/2004 of the European Parliament and of the Council relating to priority rules in the event of overlapping of family benefits (13).
 (6)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No H1 of 12 June 2009 concerning the framework for the transition from Council Regulations (EEC) No 1408/71 and (EEC) No 574/72 to Regulations (EC) No 883/2004 and (EC) No 987/2009 of the European Parliament and of the Council and the application of Decisions and Recommendations of the Administrative Commission for the coordination of social security systems (14).
 (7)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No H2 of 12 June 2009 concerning the methods of operation and the composition of the Technical Commission for data processing of the Administrative Commission for the coordination of social security systems (15).
 (8)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No H 3 of 15 October 2009 concerning the date to be taken into consideration for determining the rates of conversion referred to in Article 90 of Regulation (EC) No 987/2009 of the European Parliament and of the Council (16).
 (9)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No H 4 of 22 December 2009 concerning the composition and working methods of the Audit Board of the Administrative Commission for the Coordination of Social Security Systems (17).
 (10)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No H 5 of 18 March 2010 concerning cooperation on combating fraud and error within the framework of Council Regulation (EC) No 883/2004 and Regulation (EC) No 987/2009 of the European Parliament and of the Council on the coordination of social security systems (18).
 (11)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No P1 of 12 June 2009 on the interpretation of Articles 50(4), 58 and 87(5) of Regulation (EC) No 883/2004 of the European Parliament and of the Council for the award of invalidity, old-Age and survivors’ benefits (19).
 (12)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No S1 of 12 June 2009 concerning the European Health Insurance Card (20)..
 (13)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No S2 of 12 June 2009 concerning the technical specifications of the European Health Insurance Card (21).
 (14)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No S3 of 12 June 2009 defining the benefits covered by Articles 19(1) and 27(1) of Regulation (EC) No 883/2004 of the European Parliament and of the Council and Article 25(A) (3) of Regulation (EC) No 987/2009 of the European Parliament and of the Council (22).
 (15)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No S4 of 2 October 2009 concerning refund procedures for the implementation of Articles 35 and 41 of Regulation (EC) No 883/2004 of the European Parliament and of the Council (23).
 (16)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No S5 of 2 October 2009 on interpretation of the concept of “benefits in kind” as defined in Article 1(va) of Regulation (EC) No 883/2004 of the European Parliament and of the Council in the event of sickness or maternity pursuant to Articles 17, 19, 20, 22, 24 (1), 25, 26, 27 (1, 3, 4 and 5), 28, 34 and 36 (1 and 2) of Regulation (EC) No 883/2004 and on calculation of the amounts to be refunded under Articles 62, 63 and 64 of Regulation (EC) No 987/2009 of the European Parliament and of the Council (24).
 (17)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No S6 of 22 December 2009 concerning the registration in the Member State of residence under Article 24 of Regulation (EC) No 987/2009 and the compilation of the inventories provided for in Article 64(4) of Regulation (EC) No 987/2009 (25).
 (18)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No S7 of 22 December 2009 concerning the transition from Regulations (EEC) Nos 1408/71 and 574/72 to Regulations (EC) Nos 883/2004 and 987/2009 and the application of reimbursement procedures (26).
 (19)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No U1 of 12 June 2009 concerning Article 54(3) of Regulation (EC) No 987/2009 of the European Parliament and of the Council relating to increases in unemployment benefit for dependent members of the family (27).
 (20)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No U2 of 12 June 2009 concerning the scope of Article 65(2) of Regulation (EC) No 883/2004 of the European Parliament and of the Council on the right to unemployment benefits of wholly unemployed persons other than frontier workers who were resident in the territory of a Member State other than the competent Member State during their last period of employment or self-employment (28).
 (21)
 Decision of the Administrative Commission for the Coordination of Social Security Systems No U3 of 12 June 2009 concerning the scope of the concept of “partial unemployment” applicable to the unemployed persons referred to in Article 65(1) of Regulation (EC) No 883/2004 of the European Parliament and of the Council (29).
 SECTION C: LEGAL ACTS OF WHICH THE CONTRACTING PARTIES SHALL TAKE NOTE
 (1)
 Recommendation of the Administrative Commission for the Coordination of Social Security Systems No U1 of 12 June 2009 concerning the legislation applicable to unemployed persons engaging in part-time professional or trade activity in a Member State other than the State of residence (30).
 (2)
 Recommendation of the Administrative Commission for the Coordination of Social Security Systems No U2 of 12 June 2009 concerning the application of Article 64(1)(a) of Regulation (EC) No 883/2004 of the European Parliament and of the Council to unemployed persons accompanying their spouses or partners pursuing a professional or trade activity in a Member State other than the competent State (31).
 PROTOCOL
 to Annex II to the Agreement
 I. Unemployment insurance
 The following arrangements shall apply to workers who are nationals of the Czech Republic, the Republic of Estonia, the Republic of Latvia, the Republic of Lithuania, the Republic of Hungary, the Republic of Poland, the Republic of Slovenia and the Slovak Republic until 30 April 2011 and to workers who are nationals of the Republic of Bulgaria and Romania until 31 May 2016.
 1.
 The following rules shall apply with respect to unemployment insurance for workers holding a residence permit with a period of validity of less than one year:
 1.1.
 Only workers who have paid contributions in Switzerland for the minimum period required under the Federal Unemployment Insurance and Insolvency Allowances Act (loi fédérale sur l’assurance-chômage obligatoire et l’indemnité en cas d’insolvabilité — LACI) (32) and who also satisfy the other conditions of eligibility for unemployment benefit shall be entitled to such benefit provided by the unemployment insurance under the conditions laid down by law.
 1.2.
 A portion of the contributions levied for workers whose period of contribution is too short to give entitlement to unemployment benefit in Switzerland under 1.1 shall be refunded to their States of origin in accordance with the provisions of 1.3. in order to contribute towards the cost of benefits provided to these workers in the event of full unemployment; these workers shall then have no entitlement to benefit in the event of their being fully unemployed in Switzerland. They shall, however, be entitled to allowances for bad weather and in the event of the employer becoming insolvent. Benefits in the event of full unemployment shall be paid by the State of origin, provided that the workers concerned make themselves available for work. Periods of insurance completed in Switzerland shall be taken into account in the same way as if they had been completed in the State of origin.
 1.3.
 The portion of the contributions levied for workers referred to in 1.2 shall be refunded on an annual basis in accordance with the following provisions:
 (a)
 The total contributions of these workers shall be calculated, by country, on the basis of the annual number of workers employed and the average annual contributions paid for each worker (employer’s and employee’s contributions).
 (b)
 Of the amount calculated in this way, a portion thereof corresponding to the relative share represented by unemployment benefit as a percentage of all the allowances referred to in 1.2 shall be refunded to the workers’ States of origin, and a portion shall be retained by Switzerland as a reserve for subsequent benefits (33).
 (c)
 Switzerland shall, on an annual basis, provide a statement showing the contributions refunded. If the States of origin so request, it shall indicate the bases for the calculation and the sums refunded. The States of origin shall each year notify Switzerland of the number of recipients of unemployment benefit as referred to in 1.2.
 2.
 If a Member State concerned by this arrangement encounters difficulties with the ending of the arrangements for refunding of contributions, or Switzerland encounters difficulties with the aggregation arrangements, the matter may be referred to the Joint Committee by any of the contracting parties.
 II. Allowances for helpless persons
 Allowances for helpless persons granted under the Swiss Federal Act of 19 June 1959 on invalidity insurance (LAI) and under the Federal Act of 20 December 1946 on old-age and survivors’ pensions (LAVS) as amended on 8 October 1999 shall be provided exclusively if the person concerned resides in Switzerland.
 III. Occupational benefit plans concerning old-age, survivors’ and invalidity pensions
 Notwithstanding Article 10(2) of Regulation (EEC) No 1408/71, the vested benefit provided for under the Federal Act on free movement among occupational benefit plans concerning old-age, survivors’ and invalidity pensions (Loi fédérale sur le libre passage dans la prévoyance professionnelle vieillesse, survivants et invalidité) of 17 December 1993 shall be paid out on request to an employed or self-employed person who intends to leave Switzerland for good and who, under Title II of the Regulation, will no longer be subject to Swiss law, provided that that person leaves Switzerland within five years of this Agreement entering into effect.
 ’
 (1) OJ L 166, 30.4.2004, p. 1.
 (2) OJ L 284, 30.10.2009, p. 43.
 (3) OJ L 284, 30.10.2009, p. 1.
 (4) OJ L 149, 5.7.1971, p. 2.
 (5) OJ L 177, 4.7.2008, p. 1.
 (6) OJ L 74, 27.3.1972, p. 1.
 (7) OJ L 39, 10.2.2009, p. 29.
 (8) OJ L 209, 25.7.1998, p. 46.
 (9) OJ C 106, 24.4.2010, p. 1.
 (10) OJ C 106, 24.4.2010, p. 5.
 (11) OJ C 149, 8.6.2010, p. 3.
 (12) OJ C 106, 24.4.2010, p. 9.
 (13) OJ C 106, 24.4.2010, p. 11.
 (14) OJ C 106, 24.4.2010, p. 13.
 (15) OJ C 106, 24.4.2010, p. 17.
 (16) OJ C 106, 24.4.2010, p. 56.
 (17) OJ C 107, 27.4.2010, p. 3.
 (18) OJ C 149, 8.6.2010, p. 5.
 (19) OJ C 106, 24.4.2010, p. 21.
 (20) OJ C 106, 24.4.2010, p. 23.
 (21) OJ C 106, 24.4.2010, p. 26.
 (22) OJ C 106, 24.4.2010, p. 40.
 (23) OJ C 106, 24.4.2010, p. 52.
 (24) OJ C 106, 24.4.2010, p. 54.
 (25) OJ C 107, 27.4.2010, p. 6.
 (26) OJ C 107, 27.4.2010, p. 8.
 (27) OJ C 106, 24.4.2010, p. 42.
 (28) OJ C 106, 24.4.2010, p. 43.
 (29) OJ C 106, 24.4.2010, p. 45.
 (30) OJ C 106, 24.4.2010, p. 49.
 (31) OJ C 106, 24.4.2010, p. 51.
 (32) Currently 12 months.
 (33) Refunded contributions for workers who will exercise their right to unemployment benefit in Switzerland after having paid contributions for at least 12 months — over several periods of residence — within the space of two years.


type: other

text:
Le traitement devrait être instauré et surveillé sous le contrôle dun médecin spécialiste. La dose initiale est de 10 mg/jour, soit 2,5 ml de FLUOXETINE SANDOZ 20 mg/5 ml en solution buvable.
 Symptômes de sevrage à larrêt du traitement par FLUOXETINE SANDOZ
 Larrêt brutal du traitement doit être évité. Lors de larrêt du traitement par FLUOXETINE SANDOZ, la dose doit être progressivement diminuée sur une durée dau moins une à deux semaines, afin de limiter le risque de réactions de sevrage (voir rubriques 4.4 et 4.8). Si des symptômes insupportables apparaissent lors de la diminution de la dose ou à larrêt du traitement, le retour à la dose précédemment prescrite peut être envisagé. Le médecin pourra ensuite reprendre la diminution de la dose, mais à un rythme plus progressif.
 Des comportements de type suicidaire (tentatives de suicide et idées suicidaires) et de type hostile (principalement agressivité, comportement dopposition et colère) ont été plus fréquemment observés au cours des études cliniques chez les enfants et adolescents traités par antidépresseurs par rapport à ceux traités par placebo. FLUOXETINE SANDOZ ne devrait être utilisé chez les enfants et les adolescents âgés de 8 à 18 ans que dans le traitement dun épisode dépressif majeur (cest à dire caractérisé) modéré à sévère. FLUOXETINE SANDOZ est déconseillé dans toute autre indication. Si, en cas de nécessité clinique, la décision de traiter est néanmoins prise, le patient devra faire lobjet dune surveillance attentive pour détecter lapparition de symptômes suicidaires. De plus, les données de tolérance à long terme chez les enfants et les adolescents, dont les effets sur la croissance, la maturation sexuelle et le développement cognitif, émotionnel et comportemental sont limitées (voir rubrique 5.3).
 Les autres troubles psychiatriques dans lesquels FLUOXETINE SANDOZ est prescrit peuvent également être associés à un risque accru de comportement suicidaire. De plus, ces troubles peuvent être associés à un épisode dépressif majeur. Les mêmes précautions demploi que celles mentionnées pour les patients souffrant dépisodes dépressifs majeurs devront donc être appliquées aux patients présentant dautres troubles psychiatriques.
 Le risque de symptômes de sevrage peut dépendre de plusieurs facteurs, dont la durée du traitement, la posologie, ainsi que le rythme de diminution de la posologie. Les réactions les plus fréquentes rapportées étaient les suivantes : sensations vertigineuses, troubles sensoriels (incluant paresthésies), troubles du sommeil (incluant insomnies et rêves intenses), asthénie, agitation ou anxiété, nausées et/ou vomissements, tremblements et céphalées. Ces symptômes sont généralement dintensité légère à modérée, mais peuvent être dintensité sévère chez certains patients. Ils apparaissent habituellement dans les tous premiers jours suivant larrêt du traitement. Ils sont généralement spontanément résolutifs et disparaissent habituellement en 2 semaines, même si chez certains patients, ils peuvent se prolonger (2-3 mois ou plus). Il est donc conseillé de diminuer la posologie de FLUOXETINE SANDOZ progressivement sur une durée dau moins une à deux semaines, selon les besoins du patient (voir rubrique 4.2 : « Symptômes de sevrage à larrêt du traitement par FLUOXETINE SANDOZ »).
 14 gélules sous plaquettes thermoformées (PVC/PVDC/Aluminium)
 20 gélules sous plaquettes thermoformées (PVC/PVDC/Aluminium)
 ·34009 365 842 1 1 : 14 gélules sous plaquettes (PVC/PVDC/Aluminium).
 ·34009 354 072 5 2 : 20 gélules sous plaquettes (PVC/PVDC/Aluminium).
 ·34009 562 583 9 0 : 100 gélules sous plaquettes (PVC/PVDC/Aluminium).
 1. Qu'est-ce que FLUOXETINE SANDOZ 20 mg, gélule et dans quels cas est-il utilisé ?
 2. Quelles sont les informations à connaître avant de prendre FLUOXETINE SANDOZ 20 mg, gélule ?
 3. Comment prendre FLUOXETINE SANDOZ 20 mg, gélule ?
 5. Comment conserver FLUOXETINE SANDOZ 20 mg, gélule ?
 1. QUEST-CE QUE FLUOXETINE SANDOZ 20 mg, gélule ET DANS QUELS CAS EST-IL UTILISE ? Retour en haut de la page
 FLUOXETINE SANDOZ 20 mg, gélule contient une substance active, la fluoxétine, et fait partie dun groupe de médicaments appelés antidépresseurs inhibiteurs sélectifs de la recapture de la sérotonine (ISRS).
 ·soit la boulimie : FLUOXETINE SANDOZ est utilisé en complément d'une psychothérapie pour la diminution de la fréquence des crises de boulimie, des vomissements ou de la prise de laxatifs.
 Un épisode dépressif modéré à sévère qui ne répond pas à une prise en charge psychothérapeutique après 4 à 6 séances. Chez les enfants et adolescents présentant un épisode dépressif modéré à sévère, FLUOXETINE SANDOZ ne devrait être proposé quen association avec une prise en charge psychothérapeutique.
 2. QUELLES SONT LES INFORMATIONS A CONNAITRE AVANT DE PRENDRE FLUOXETINE SANDOZ 20 mg, gélule ? Retour en haut de la page
 Ne prenez jamais FLUOXETINE SANDOZ 20 mg, gélule
 Le traitement par FLUOXETINE SANDOZ ne doit être commencé que 2 semaines après l'arrêt de l'IMAO non sélectif et irréversible.
 Ne prenez aucun IMAO non sélectif et irréversible pendant au minimum 5 semaines après l'arrêt de votre traitement par FLUOXETINE SANDOZ. Si FLUOXETINE SANDOZ vous a été prescrit pendant une longue durée et/ou à des doses élevées, votre médecin devra envisager un intervalle de temps plus long.
 Adressez-vous à votre médecin ou pharmacien avant de prendre FLUOXETINE SANDOZ 20 mg, gélule dans les situations suivantes :
 ·Début de fièvre, spasme musculaire ou tremblements, modifications de votre état mental tels que confusion, irritabilité et importante agitation : il peut sagir dun syndrome appelé « syndrome sérotoninergique » ou « syndrome malin des neuroleptiques ». Bien que ce syndrome napparaisse que rarement, il peut menacer le pronostic vital, contactez votre médecin immédiatement, car le traitement par FLUOXETINE SANDOZ pourrait devoir être arrêté.
 ·Manie ou antécédents de manie : en cas de survenue dun état maniaque, contactez votre médecin immédiatement, il pourrait arrêter le traitement par FLUOXETINE SANDOZ.
 ·Prise de médicaments qui agissent sur la coagulation du sang : voir rubrique « Autres médicaments et FLUOXETINE SANDOZ 20 mg, gélule».
 ·Convulsions ou antécédents dépilepsie : en cas de crise convulsive ou si vous constatez que la fréquence des crises augmente, contactez votre médecin immédiatement, il pourrait arrêter le traitement par FLUOXETINE SANDOZ.
 ·Traitement en cours par le tamoxifène (utilisé dans le traitement du cancer du sein) : voir rubrique « Autres médicaments et FLUOXETINE SANDOZ 20 mg, gélule».
 ·Impatiences, impossibilité de rester assis ou debout tranquillement (akathisie). Une augmentation des doses de FLUOXETINE SANDOZ peut aggraver ces symptômes.
 Les patients de moins de 18 ans présentent un risque accru d'effets indésirables, tels que tentative de suicide, pensées suicidaires et comportement hostile (principalement agressivité, comportement d'opposition et colère) lorsqu'ils sont traités par cette classe de médicaments. FLUOXETINE SANDOZ ne doit être utilisé chez les enfants et adolescents âgés de 8 à 18 ans que dans le cadre du traitement dun épisode dépressif modéré à sévère (en association à une psychothérapie) et ne doit pas être utilisé dans dautres indications.
 Les données de sécurité demploi à long terme de fluoxétine, concernant la croissance, la puberté, le développement psychique, émotionnel et comportemental chez les patients de cette tranche dâge sont limitées. Néanmoins, si vous êtes âgé de moins de 18 ans, il est possible que votre médecin décide de vous prescrire FLUOXETINE SANDOZ si vous souffrez d'épisodes dépressifs modérés à sévères en association avec une psychothérapie, si il/elle décide que c'est dans votre intérêt. Si votre médecin a prescrit FLUOXETINE SANDOZ à un patient de moins de 18 ans et que vous désirez en discuter, adressez-vous à lui. Vous devez informer votre médecin si l'un des symptômes énumérés ci-dessus apparaît ou s'aggrave chez un patient de moins de 18 ans prenant FLUOXETINE SANDOZ.
 Autres médicaments et FLUOXETINE SANDOZ 20 mg, gélule
 Ne prenez pas FLUOXETINE SANDOZ avec :
 ·Certains IMAO non sélectifs et irréversibles (dont certains utilisés pour traiter la dépression) : les IMAO non sélectifs et irréversibles ne doivent pas être utilisés avec FLUOXETINE SANDOZ (voir rubrique « Ne prenez jamais FLUOXETINE SANDOZ 20 mg, gélule »), car des effets graves voire fatals (syndrome sérotoninergique) peuvent survenir. Le traitement par FLUOXETINE SANDOZ ne doit être débuté quaprès avoir arrêté un IMAO non sélectif et irréversible (par exemple tranylcypromine) depuis au moins deux semaines. Ne prenez aucun IMAO non sélectif et irréversible pendant au moins 5 semaines après que vous ayez arrêté votre traitement par FLUOXETINE SANDOZ. Si FLUOXETINE SANDOZ vous a été prescrit pour une longue période et/ou à une forte dose, votre médecin pourra être amené à envisager un intervalle dune durée de plus de 5 semaines entre la prise de FLUOXETINE SANDOZ et dun IMAO non sélectif et irréversible.
 ·Le tamoxifène (utilisé dans le traitement du cancer du sein) : FLUOXETINE SANDOZ peut modifier les concentrations de ce médicament dans le sang, avec pour conséquence possible une diminution des effets du tamoxifène. Votre médecin peut décider de changer votre traitement antidépresseur.
 ·La méquitazine (utilisée contre les allergies), car lutilisation de ce médicament avec FLUOXETINE SANDOZ peut augmenter le risque de modification de lactivité électrique de votre cur.
 ·La phénytoïne (contre lépilepsie) car FLUOXETINE SANDOZ pouvant modifier le taux de ce médicament dans le sang, votre médecin pourrait être amené à instaurer la phénytoïne avec plus de précautions et à effectuer des bilans plus fréquemment.
 ·Le lithium, la sélégiline, le millepertuis, le tramadol (un antidouleur), les triptans (contre les migraines) et le tryptophane : lorsquils sont administrés en association avec FLUOXETINE SANDOZ, il existe un risque augmenté de léger syndrome sérotoninergique. Votre médecin devra effectuer des bilans plus fréquemment.
 ·Les médicaments pouvant perturber le rythme cardiaque comme par exemple des antiarythmiques de Classe IA et III, des antipsychotiques (par exemple les dérivés de la phénothiazine, le pimozide, lhalopéridol), les antidépresseurs tricycliques, certains agents antimicrobiens (par exemple la sparfloxacine, la moxifloxacine, lérythromycine IV, la pentamidine), les traitements antipaludiques, en particulier lhalofantrine ou certains antihistaminiques (astemizole, mizolastine) car lutilisation dun ou plus de ces médicaments avec FLUOXETINE SANDOZ peut augmenter le risque de modification de lactivité électrique de votre cur.
 ·Les anticoagulants (comme la warfarine), les anti-inflammatoires non stéroïdiens (AINS) (comme libuprofène, le diclofénac), laspirine et autres médicaments pouvant fluidifier le sang (y compris la clozapine, utilisé dans le traitement de certains troubles mentaux). FLUOXETINE SANDOZ peut modifier les effets de ces médicaments sur le sang. Si le traitement par FLUOXETINE SANDOZ est commencé ou arrêté pendant votre traitement par la warfarine, votre médecin aura besoin de réaliser certains tests, dadapter votre dose et deffectuer des contrôles plus fréquemment.
 ·La cyproheptadine (contre les allergies) ; car elle peut diminuer leffet de FLUOXETINE SANDOZ.
 ·Les médicaments qui diminuent le taux de sodium dans le sang (y compris les médicaments qui provoque une augmentation du besoin duriner, la desmopressine, la carbamazepine et loxcarbazepine) ; car ces médicaments peuvent augmenter le risque que le taux de sodium dans votre sang ne devienne trop bas sils sont pris avec FLUOXETINE SANDOZ.
 ·Les antidépresseurs tels que les antidépresseurs tricycliques, les inhibiteurs sélectifs de la recapture de la sérotonine (ISRSs) ou le bupropion, la méfloquine ou la chloroquine (utilisés dans le traitement du paludisme), le tramadol (utilisé dans le traitement de la douleur sévère) ou les antipsychotiques tels que les phénothiazines ou les butyrophénones ; car FLUOXETINE SANDOZ peut augmenter le risque de convulsion sil est pris en association avec ces médicaments.
 ·La flécaïnide, le propafénone, le nébivolol ou lencaïnide (dans les problèmes cardiaques), la carbamazépine (contre lépilepsie), latomoxétine ou les antidépresseurs tricycliques (par exemple, imipramine, desipramine et amytriptyline) ou la rispéridone (contre la schizophrénie) car FLUOXETINE SANDOZ pouvant modifier les taux de ces médicaments dans le sang, votre médecin pourrait avoir besoin de diminuer leur dose lorsquils sont administrés avec FLUOXETINE SANDOZ.
 FLUOXETINE SANDOZ 20 mg, gélule avec des aliments, boissons et de lalcool
 ·FLUOXETINE SANDOZ peut être pris pendant ou hors des repas, selon votre préférence.
 ·Vous devez éviter toute prise d'alcool pendant votre traitement par FLUOXETINE SANDOZ.
 FLUOXETINE SANDOZ 20 mg, gélule contient du lactose.
 3. COMMENT PRENDRE FLUOXETINE SANDOZ 20 mg, gélule ? Retour en haut de la page
 ·Troubles obsessionnels compulsifs : la dose recommandée est de 1 gélule (20 mg) par jour. Votre médecin reverra et adaptera la dose si nécessaire après 2 semaines de traitement. Si nécessaire, la dose peut être augmentée progressivement jusqu'à une dose maximale de 3 gélules (60 mg) par jour. Si aucune amélioration n'est constatée dans les 10 semaines, votre médecin évaluera la nécessité de poursuivre le traitement par FLUOXETINE SANDOZ.
 Le traitement doit être initié et supervisé par un spécialiste. La dose initiale est de 10 mg/jour (correspondant à 2,5 ml de FLUOXETINE SANDOZ 20 mg/5 ml en solution buvable). Après une à deux semaines de traitement, votre médecin pourra augmenter la dose à 20 mg/jour La dose doit être augmentée avec prudence afin de garantir que vous ne receviez que la dose minimale efficace. Les enfants de faible poids peuvent nécessiter des doses plus faibles. Si la réponse au traitement est satisfaisante, votre médecin évaluera la nécessité de poursuivre le traitement au-delà de 6 mois. Si aucune amélioration n'est constatée dans les 9 semaines, votre médecin réévaluera la nécessité de poursuivre le traitement.
 Si vous avez des problèmes de foie ou prenez d'autres médicaments qui peuvent avoir un effet sur la fluoxétine, votre médecin peut décider de vous prescrire une dose plus faible ou vous demander de prendre FLUOXETINE SANDOZ un jour sur deux.
 Si vous avez pris plus de FLUOXETINE SANDOZ 20 mg, gélule que vous nauriez dû :
 Si vous oubliez de prendre FLUOXETINE SANDOZ 20 mg, gélule :
 Si vous arrêtez de prendre FLUOXETINE SANDOZ 20 mg, gélule :
 Il est possible que vous ressentiez les symptômes suivants à l'arrêt du traitement par FLUOXETINE SANDOZ : sensations de vertiges, sensations de picotements d'aiguille, troubles du sommeil (rêves agités, cauchemars, insomnie) ; sensation de nervosité ou d'agitation, fatigue ou faiblesse inhabituelles, anxiété, nausées/vomissements, tremblements, maux de tête.
 La plupart du temps, les symptômessurvenant à l'arrêt du traitement par FLUOXETINE SANDOZ sont ressentis comme modérés et disparaissent d'eux-mêmes en quelques semaines. Si vous ressentez de tels symptômes, contactez votre médecin.
 Lors de l'arrêt de FLUOXETINE SANDOZ, votre médecin vous aidera à réduire progressivement les doses sur une à deux semaines ceci afin de réduire le risque d'apparition de symptômes de sevrage.
 ·Si vous avez à un moment quelconque des idées suicidaires ou dauto-agression, contactez immédiatement votre médecin ou allez directement à lhôpital (voir rubrique 2 « QUELLES SONT LES INFORMATIONS A CONNAITRE AVANT DE PRENDRE FLUOXETINE SANDOZ 20 mg, gélule ? »).
 ·Si vous vous sentez nerveux, que vous avez une incapacité déplaisante à rester assis ou debout tranquillement, vous pouvez présenter une akathisie ; laugmentation des doses de FLUOXETINE SANDOZ peut aggraver ces symptômes. Si vous ressentez ces symptômes, contactez votre médecin
 En outre, chez les enfants et les adolescents (8-18 ans) :En plus des effets indésirables listés ci-dessus, FLUOXETINE SANDOZ peut induire un ralentissement de la croissance et de la puberté. Des comportements de type suicidaire (tentatives de suicide et idées suicidaires), de type hostile, de manie, et des saignements de nez ont été fréquemment rapportés chez les enfants.
 5. COMMENT CONSERVER FLUOXETINE SANDOZ 20 mg, gélule ? Retour en haut de la page
 Ce que contient FLUOXETINE SANDOZ 20 mg, gélule Retour en haut de la page
 Quest-ce que FLUOXETINE SANDOZ 20 mg, gélule et contenu de lemballage extérieur Retour en haut de la page
 Ce médicament se présente sous forme de gélule. Boîte de 14, 20 ou 100.


text:
Andy Pengelly (born 19 July 1997) is an Australian professional footballer who plays as a striker for Lions FC in the National Premier Leagues.
 Club career
 Brisbane Strikers
 In 2019, Pengelly won the National Premier Leagues Queensland Golden Boot, scoring 41 goals in 26 NPL appearances for Brisbane Strikers, including a club record nine in a single match against Sunshine Coast Fire. He also scored 11 goals in eight FFA Cup appearances, including six in a Round 4 Preliminary clash against Souths United. He scored against A-League side Wellington Phoenix in the Round of 32, helping his side to a penalty shootout win, and against Melbourne City in a 5–1 semi final loss, lifting his season tally to 52 goals in just 34 appearances.
 As a result of his scoring record, Pengelly trialled with the Central Coast Mariners in August 2019. That trial did not result in a contract.
 Lion City Sailors
 Pengelly signed his first professional contract with Singapore Premier League club Home United in December 2019. Prior to the start of the 2020 season, the club was taken over and its name changed to Lion City Sailors. Pengelly scored on his competitive debut for the Sailors in their 1–1 away draw with Tanjong Pagar United on Friday, 6 March 2020, in what was the club's' first ever goal as the Sailors.
 On 15 July 2020, it was announced Pengelly had parted ways with the club to remain in Australia, where he had returned during the global COVID-19 pandemic, to sign for NPL side Peninsula Power.
 Peninsula Power
 Pengelly signed for Peninsula Power from the Brisbane Strikers, but left for Singapore to play for Lion City Sailors before he kicked a ball for the Redcliffe peninsula-based club.
 His first game for the Power came after he returned to Queensland during the COVID-19 pandemic, joining the side late in the 2020 season. He scored 14 goals in 15 league games that year.
 In his first full season, in 2021, Pengelly scored 30 goals in 27 league appearances for the Power, taking out the NPL Queensland Golden Boot and the competition's Player of the Year award.
 Lions FC
 On December 23, 2021, Lions FC announced Pengelly as their number 9 for the 2022 NPL Queensland season.
 Career statistics
 Club
 Notes
 Honours
 Brisbane Strikers
 NPL Queensland: Golden Boot (2019)
 Peninsula Power
 NPL Queensland: Premiers (2020, 2021)
 NPL Queensland: Golden Boot (2021)
 NPL Queensland: Player of the Year (2021)
 Lions FC
 NPL Queensland: Premiers (2022)
 References
 Living people
 1997 births
 Association football forwards
 Australian soccer players
 Brisbane Strikers FC players
 National Premier Leagues players
 Singapore Premier League players
 Lion City Sailors FC players


type: legislation

text:
 21.12.2013
 BG
 Официален вестник на Европейския съюз
 L 349/58
 РЕГЛАМЕНТ ЗА ИЗПЪЛНЕНИЕ (ЕС) No 1399/2013 НА КОМИСИЯТА
 от 18 декември 2013 година
 за вписване на название в регистъра на защитените наименования за произход и защитените географски указания (Antep Baklavası/Gaziantep Baklavası (ЗГУ)
 ЕВРОПЕЙСКАТА КОМИСИЯ,
 като взе предвид Договора за функционирането на Европейския съюз,
 като взе предвид Регламент (ЕС) No 1151/2012 на Европейския парламент и на Съвета от 21 ноември 2012 г. относно схемите за качество на селскостопанските продукти и храни (1), и по-специално член 52, параграф 2 от него,
 като има предвид, че:
 (1)
 В съответствие с член 50, параграф 2, буква а) от Регламент (ЕС) No 1151/2012 заявката за регистрация на названието „Antep Baklavası“/„Gaziantep Baklavası“, подадена от Gaziantep Sanayi Odasi (Търговска палата на Gaziantep), бе публикувана в Официален вестник на Европейския съюз
 (2).
 (2)
 Тъй като Комисията не е получила никакви възражения по член 51 от Регламент (ЕС) No 1151/2012, названието „Antep Baklavası“/„Gaziantep Baklavası“ следва да бъде регистрирано,
 ПРИЕ НАСТОЯЩИЯ РЕГЛАМЕНТ:
 Член 1
 Регистрира се названието, посочено в приложението към настоящия регламент.
 Член 2
 Настоящият регламент влиза в сила на двадесетия ден след публикуването му в Официален вестник на Европейския съюз.
 Настоящият регламент е задължителен в своята цялост и се прилага пряко във всички държави членки.
 Съставено в Брюксел на 18 декември 2013 година.
 За Комисията, от името на председателя,
 Dacian CIOLOȘ
 Член на Комисията
 (1) ОВ L 343, 14.12.2012 г., стр. 1.
 (2) ОВ C 229, 8.8.2013 г., стр. 43.
 ПРИЛОЖЕНИЕ
 Селскостопански продукти и храни, посочени в точка I от приложение I към Регламент (ЕС) No 1151/2012:
 Клас 2.4. Хляб, хлебни изделия, сладкарски и захарни изделия, бисквити и други печива
 ТУРЦИЯ
 Antep Baklavası/Gaziantep Baklavası (ЗГУ)


text:
 7.4.2011
 FR
 Journal officiel de l'Union européenne
 L 93/33
 DÉCISION DU COMITÉ MIXTE DE L’EEE
 No 5/2011
 du 11 février 2011
 modifiant l’annexe XIII (Transports) de l’accord EEE
 LE COMITÉ MIXTE DE L’EEE,
 vu l’accord sur l’Espace économique européen, modifié par le protocole portant adaptation de cet accord, ci-après dénommé «l’accord», et notamment son article 98,
 considérant ce qui suit:
 (1)
 L’annexe XIII de l’accord a été modifiée par la décision du Comité mixte de l’EEE no 140/2010 du 10 décembre 2010 (1).
 (2)
 Le règlement (CE) no 300/2008 du Parlement européen et du Conseil du 11 mars 2008 relatif à l’instauration de règles communes dans le domaine de la sûreté de l’aviation civile et abrogeant le règlement (CE) no 2320/2002 (2) a été intégré dans l’accord par la décision du Comité mixte de l’EEE no 69/2009 du 29 mai 2009 (3), accompagné d’adaptations en vue de tenir compte de la situation spécifique de certains pays.
 (3)
 La décision C(2010) 774 final de la Commission du 13 avril 2010 définissant des mesures détaillées pour la mise en œuvre des règles communes dans le domaine de la sûreté de l’aviation contenant des informations visées à l’article 18, point a), du règlement (CE) no 300/2008 doit être intégrée dans l’accord.
 (4)
 La décision C(2010) 2604 final de la Commission du 23 avril 2010 modifiant la décision 2010/774/UE de la Commission du 13 avril 2010 définissant des mesures détaillées pour la mise en œuvre des règles communes dans le domaine de la sûreté de l’aviation contenant des informations visées à l’article 18, point a), du règlement (CE) no 300/2008 doit être intégrée dans l’accord.
 (5)
 La décision C(2010) 774 final abroge la décision C(2008) 4333 final de la Commission du 8 août 2008 fixant des mesures supplémentaires pour la mise en œuvre des règles communes dans le domaine de la sûreté aérienne, qui est intégrée dans l’accord et doit donc en être supprimée.
 (6)
 Toutes les mesures nécessaires pour assurer l’applicabilité du règlement (CE) no 300/2008 de la Commission (4) auront ainsi été intégrées dans l’accord et les règlements de la Commission (CE) no 272/2009 (5), (UE) no 1254/2009 (6), (UE) no 72/2010 (7) et (UE) no 185/2010 (8) deviendront applicables à compter de la date d’entrée en vigueur de la présente décision.
 (7)
 Toutes les mesures nécessaires pour assurer l’applicabilité du règlement (CE) no 300/2008 auront ainsi été intégrées dans l’accord et le règlement (CE) no 2320/2002 du Parlement européen et du Conseil (9) et les règlements de la Commission (CE) no 1217/2003 (10), (CE) no 1486/2003 (11), (CE) no 1138/2004 (12) et (CE) no 820/2008 (13) seront supprimés de l’accord à compter de la date d’entrée en vigueur de la présente décision,
 DÉCIDE:
 Article premier
 L’annexe XIII de l’accord est modifiée comme suit:
 1)
 Le texte suivant est ajouté après le point 66he [règlement (UE) no 185/2010 de la Commission]:
 «66hf.
 C(2010) 774 final: décision C(2010) 774 final de la Commission du 13 avril 2010 définissant des mesures détaillées pour la mise en œuvre des règles communes dans le domaine de la sûreté de l’aviation contenant des informations visées à l’article 18, point a), du règlement (CE) no 300/2008, modifiée par:
 —
 C(2010) 2604 final: décision C(2010) 2604 final de la Commission du 23 avril 2010.»
 2)
 Le texte du point 66ia [décision C(2008) 4333 final de la Commission] est supprimé.
 Article 2
 La présente décision entre en vigueur le 12 février 2011, pour autant que toutes les notifications prévues à l’article 103, paragraphe 1, de l’accord aient été faites au Comité mixte de l’EEE (14).
 Article 3
 La présente décision est publiée dans la partie EEE et dans le supplément EEE du Journal officiel de l’Union européenne.
 Fait à Bruxelles, le 11 février 2011.
 Par le Comité mixte de l’EEE
 Le président faisant fonction
 Gianluca GRIPPA
 (1) JO L 85 du 31.3.2011, p. 25.
 (2) JO L 97 du 9.4.2008, p. 72.
 (3) JO L 232 du 3.9.2009, p. 25.
 (4) Règlement (CE) no 272/2009 de la Commission du 2 avril 2009, règlement (UE) no 1254/2009 de la Commission du 18 décembre 2009, règlement (UE) no 18/2010 de la Commission du 8 janvier 2010, règlement (UE) no 72/2010 de la Commission du 26 janvier 2010, règlement (UE) no 185/2010 de la Commission du 4 mars 2010, règlement (UE) no 297/2010 de la Commission du 9 avril 2010, règlement (UE) no 357/2010 de la Commission du 23 avril 2010, règlement (UE) no 358/2010 de la Commission du 23 avril 2010, décision C(2010) 774 final de la Commission du 13 avril 2010 et décision C(2010) 2604 final de la Commission du 23 avril 2010.
 (5) JO L 91 du 3.4.2009, p. 7.
 (6) JO L 338 du 19.12.2009, p. 17.
 (7) JO L 23 du 27.1.2010, p. 1.
 (8) JO L 55 du 5.3.2010, p. 1.
 (9) JO L 355 du 30.12.2002, p. 1.
 (10) JO L 169 du 8.7.2003, p. 44.
 (11) JO L 213 du 23.8.2003, p. 3.
 (12) JO L 221 du 22.6.2004, p. 6.
 (13) JO L 221 du 19.8.2008, p. 8.
 (14) Pas d’obligations constitutionnelles signalées.


text:
 A BIZOTTSÁG (EU) .../... VÉGREHAJTÁSI RENDELETE
 (2018.4.19.)
 a tengerészeti felszerelések elektronikus címkéire vonatkozó műszaki kritériumok meghatározásáról
 (EGT-vonatkozású szöveg)
 AZ EURÓPAI BIZOTTSÁG,
 tekintettel az Európai Unió működéséről szóló szerződésre,
 tekintettel a tengerészeti felszerelésekről és a 96/98/EK tanácsi irányelv hatályon kívül helyezéséről szóló, 2014. július 23-i 2014/90/EU irányelvre
 1
 , és különösen annak 11. cikke (4) bekezdésére,
 mivel:
 (1)A 2014/90/EU irányelv végrehajtási hatásköröket ruház a Bizottságra abból a célból, hogy a tervezés, a teljesítmény, valamint az elektronikus címke rögzítése és használata tekintetében meghatározza a megfelelő műszaki kritériumokat.
 (2)Költség-haszon elemzés készült
 2
 , amely a hajókormány-embléma helyettesítésére szolgáló elektronikus címkék használatát illetően kedvező eredménnyel zárult.
 (3)A tengerészeti felszerelések elektromos címkézése nem igényel jelentős befektetést, ugyanakkor a gyártók, a hajótulajdonosok és a piacfelügyeleti hatóságok számára is előnyös.
 (4)Az e rendeletben előírt feltételek összeállítására az elérhető technológiák költség-haszon elemzés keretében elvégzett összehasonlítása, valamint a költség-haszon elemzésnek a tengerészeti felszerelések azonosítására használható kódok megfelelő felépítésére vonatkozó javaslatai alapján került sor.
 (5)A létező adathordozók és adatcsere-struktúrák költség-haszon elemzés keretében elvégzett összehasonlítása vezetett a legmegfelelőbb technológiaként az adatmátrix kódok és a rádiófrekvenciás azonosítás (RFID) használatára vonatkozó ajánláshoz.
 (6)A költség-haszon elemzés azt is jelezte, hogy az elektronikus címke korlátozott adattárolási kapacitása maga után vonja, hogy az elektronikus címkének egy olyan adatbázisokhoz vezető hivatkozást kell tartalmaznia, amelyekben részletesebb információk is megtalálhatók. Az adatmátrixkódok és az e rendeletben meghatározott rádiófrekvenciás azonosítás (RFID) tartalmazza az ilyen hivatkozás biztosítására alkalmas kulcsinformációt.
 (7)Következésképpen a tengerészeti felszerelések azonosítására az elektronikus címke típusától független, szabványosított kódstruktúrán alapuló egyedi azonosítót kell használni. Az ilyen azonosításnak elég rugalmasnak kell lennie ahhoz, hogy a felhasználók számára biztosítsa a tengerészeti felszerelések legfontosabb adatbázisaihoz való közvetlen hozzáférést.
 (8)A kért adatokat ISO-szabványon alapuló formátumban kell az adathordozóra kódolni. A formátumnak lehetővé kell tennie, hogy a gyártók további adatokat is kódolhassanak, különösen azért, hogy a kalóztermékek könnyebb azonosíthatósága érdekében lehetőségük legyen arra, hogy további biztonsági elemeket foglaljanak az adathordozóba.
 (9)Annak érdekében, hogy szemrevételezéssel könnyen felismerhetők legyenek, a hajókormány-emblémát helyettesítő elektronikus címkével ellátott tengerészeti felszereléseket megfelelő szimbólummal kell ellátni.
 (10)Az e rendeletben előírt intézkedések összhangban vannak a tengeri közlekedés biztonságával és a hajókról történő szennyezés megelőzésével foglalkozó bizottság (COSS) véleményével,
 ELFOGADTA EZT A RENDELETET:
 1. cikk
 E rendelet alkalmazásában:
 1. „elektronikus címke”: rádiófrekvenciás azonosítással vagy adatmátrixkóddal ellátott marker.
 2. „alkalmazásazonosító”: a kódolt adatelemek jelentésének és formátumának meghatározására szolgáló numerikus előtag.
 2. cikk
 A tengerészeti felszerelések gyártói a mellékletben meghatározott következő elektronikus címkéket használhatják:
 a) a tengerészeti felszerelés adott darabjára tartósan rögzített RFID-címke,
 b) a tengerészeti felszerelés adott darabjára tartósan rögzített, adatmátrixkódokat tartalmazó, optikailag olvasható címkék, vagy
 c) a tengerészeti felszerelés adott darabján tartós jelöléssel, adatmátrixkódokat tartalmazó, optikailag olvasható címkék.
 3. cikk
 A hajókormány-emblémát helyettesítő RFID elektronikus címkéken láthatóan, olvashatóan és kitörölhetetlenül fel kell tüntetni a melléklet 3.1. vagy 3.2. pontjában meghatározott szimbólumot, akár magukon a címkéken, akár azok mellett.
 A hajókormány-emblémát helyettesítő optikailag olvasható, adatmátrixkódokat tartalmazó címkékkel ellátott tengerészeti felszerelésen láthatóan, olvashatóan és kitörölhetetlenül fel kell tüntetni a melléklet 3.3. pontjában meghatározott szimbólumot, akár magukon a címkéken, akár azok mellett.
 4. cikk
 Ez a rendelet az Európai Unió Hivatalos Lapjában való kihirdetését követő huszadik napon lép hatályba.
 Ez a rendelet teljes egészében kötelező és közvetlenül alkalmazandó valamennyi tagállamban.
 Kelt Brüsszelben, -án/-én. 2018.4.19.
 a Bizottság részéről
 elnök
 Jean-Claude JUNCKER
 (1)
 HL L 257., 2014.8.28., 146. o.
 (2)
 „A tengerészeti felszereléseken lévő hajókormány-embléma kiegészítésére vagy helyettesítésére szolgáló elektronikus címke esetleges bevezetéséről”, Az Európai Bizottság Mobilitáspolitikai és Közlekedési Főigazgatóságának MOVE/D2/2015-372 V1.0 számú ajánlati felhívása.
 ---documentbreak---
 MELLÉKLET
 1.A tengerészeti felszerelések azonosítása
 1.1.A tengerészeti felszerelések elektronikus címkéjének rádiófrekvenciás azonosítással (RFID) elektronikusan olvasható azonosítót vagy optikailag olvasható adatmátrixkódot kell magában foglalnia, amely a következő információkat tartalmazza:
 a) az ISO/IEC 15434:2006 és az ISO/IEC 15418:2016 szabvánnyal összhangban lévő megfelelő alkalmazásazonosító, vagy az ASC MH10 adatazonosító vagy a GS1 alkalmazásazonosító használatával,
 b) a megfelelőségértékeléshez használt, a 2014/90/EU irányelv II. mellékletében meghatározott megfelelőségértékelési modul(ok) típusa (egy alfabetikus karakter),
 c) a bejelentett szervezet számára a Bizottság által a 2014/90/EU irányelv IV. mellékletének 3.1. pontjával összhangban kiadott azonosító szám (4 számjegy),
 d) az egyedi termékellenőrzés száma(i) (G. modul) vagy az EK-típusvizsgálat és a típustanúsítványoknak való megfelelőség száma (B. és D., E. vagy F. modul) (legfeljebb 20 alfanumerikus karakter).
 1.2.Az 1.1. pont értelmében megadott adatokon túl az elektronikus címke tartalmazhat még információkat a gyártóüzem számára, a termékkódra, a tételszámra és/vagy a gyártó által az ISO/IEC 15434:2006 szabvánnyal összhangban kialakított további információkra vonatkozóan (ASC MH10 adatazonosítók vagy GS1 alkalmazásazonosítók használatával).
 1.3.Példák:
 B+D modul: (lásd az 1.2. pontot)+([megfelelő azonosító]) B 0575 40123+D 0038 040124
 B+E modul: (lásd az 1.2. pontot)+([megfelelő azonosító]) B 0575 40123+E 0038 040125
 B+F modul: (lásd az 1.2. pontot)+([megfelelő azonosító]) B 0575 40123+F 0038 040126
 G modul: (lásd az 1.2. pontot)+([megfelelő azonosító]) G 0575 040126.
 2.Elektronikus címke
 2.1.RFID-címkék
 Az RFID-válaszjeladók az ISO/IEC 18000-6:2004 C típusnak megfelelően 860 MHz és 960 MHz közötti frekvenciatartományban üzemelhetnek.
 Az elektronikus címkét úgy kell tartósan és szilárdan az érintett tengerészeti felszerelésre rögzíteni, hogy az elektronikus címke a tengerészeti felszerelés várható élettartama alatt a rendeltetése szerint olvasható legyen.
 2.2.Adatmátrixkódok
 Az adatmátrixkódoknak meg kell felelniük az ISO/IEC 16022:2006 szabványnak.
 Az elektronikus címkét úgy kell tartósan jelölni vagy szilárdan rögzíteni az érintett tengerészeti felszerelésen, hogy az elektronikus címke a tengerészeti felszerelés várható élettartama alatt a rendeltetése szerint olvasható legyen.
 3.Jelölések
 3.1.
 3.2.
 3.3.